{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 619737, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:27:14Z", "timestamp": 1574479634828}, "reference-count": 49, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 3, 1]], "date-time": "2011-03-01T00:00:00Z", "timestamp": 1298937600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2015, 12, 2]], "date-time": "2015-12-02T00:00:00Z", "timestamp": 1449014400000}, "delay-in-days": 1737, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Investigative Dermatology"], "published-print": {"date-parts": [[2011, 3]]}, "DOI": "10.1038/jid.2010.340", "type": "journal-article", "created": {"date-parts": [[2010, 11, 18]], "date-time": "2010-11-18T09:43:16Z", "timestamp": 1290073396000}, "page": "677-687", "source": "Crossref", "is-referenced-by-count": 259, "title": ["Integrative Responses to IL-17 and TNF-\u03b1 in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis"], "prefix": "10.1016", "volume": "131", "author": [{"given": "Andrea", "family": "Chiricozzi", "sequence": "first", "affiliation": []}, {"given": "Emma", "family": "Guttman-Yassky", "sequence": "additional", "affiliation": []}, {"given": "Mayte", "family": "Su\u00e1rez-Fari\u00f1as", "sequence": "additional", "affiliation": []}, {"given": "Kristine E.", "family": "Nograles", "sequence": "additional", "affiliation": []}, {"given": "Suyan", "family": "Tian", "sequence": "additional", "affiliation": []}, {"given": "Irma", "family": "Cardinale", "sequence": "additional", "affiliation": []}, {"given": "Sergio", "family": "Chimenti", "sequence": "additional", "affiliation": []}, {"given": "James G.", "family": "Krueger", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Investigative Dermatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022202X15351757?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022202X15351757?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 6]], "date-time": "2019-06-06T10:39:25Z", "timestamp": 1559817565000}, "score": 69.87592, "issued": {"date-parts": [[2011, 3]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2011, 3]]}, "issue": "3"}, "alternative-id": ["S0022202X15351757"], "URL": "http://dx.doi.org/10.1038/jid.2010.340", "ISSN": ["0022-202X"], "issn-type": [{"value": "0022-202X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T01:35:49Z", "timestamp": 1574559349729}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 10, 1]], "date-time": "2014-10-01T00:00:00Z", "timestamp": 1412121600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Actas Dermo-Sifiliogr\u00e1ficas"], "published-print": {"date-parts": [[2014, 10]]}, "DOI": "10.1016/s0001-7310(14)70014-6", "type": "journal-article", "created": {"date-parts": [[2014, 11, 11]], "date-time": "2014-11-11T15:30:49Z", "timestamp": 1415719849000}, "page": "9-20", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Pathogenic role of IL-17 in psoriasis and psoriatic arthritis"], "prefix": "10.1016", "volume": "105", "author": [{"given": "A.", "family": "Chiricozzi", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Actas Dermo-Sifiliogr\u00e1ficas"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0001731014700146?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0001731014700146?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T21:29:21Z", "timestamp": 1538083761000}, "score": 49.36792, "issued": {"date-parts": [[2014, 10]]}, "references-count": 0, "alternative-id": ["S0001731014700146"], "URL": "http://dx.doi.org/10.1016/s0001-7310(14)70014-6", "ISSN": ["0001-7310"], "issn-type": [{"value": "0001-7310", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T01:12:49Z", "timestamp": 1575508369274}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 9, 1]], "date-time": "2019-09-01T00:00:00Z", "timestamp": 1567296000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["jidonline.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Investigative Dermatology"], "published-print": {"date-parts": [[2019, 9]]}, "DOI": "10.1016/j.jid.2019.07.362", "type": "journal-article", "created": {"date-parts": [[2019, 9, 4]], "date-time": "2019-09-04T13:48:52Z", "timestamp": 1567604932000}, "page": "S276", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["360 miR-378a is overexpressed in psoriasis keratinocytes and potentiates IL-17A-mediated inflammatory responses"], "prefix": "10.1016", "volume": "139", "author": [{"given": "L.", "family": "Pasquali", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Xia", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Srivastava", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pivarcsi", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Sonkoly", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Investigative Dermatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022202X1932216X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022202X1932216X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 5]], "date-time": "2019-09-05T00:35:43Z", "timestamp": 1567643743000}, "score": 35.201797, "issued": {"date-parts": [[2019, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 9]]}, "issue": "9"}, "alternative-id": ["S0022202X1932216X"], "URL": "http://dx.doi.org/10.1016/j.jid.2019.07.362", "ISSN": ["0022-202X"], "issn-type": [{"value": "0022-202X", "type": "print"}], "subject": ["Cell Biology", "Biochemistry", "Molecular Biology", "Dermatology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "360 miR-378a is overexpressed in psoriasis keratinocytes and potentiates IL-17A-mediated inflammatory responses", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Investigative Dermatology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jid.2019.07.362", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2019 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:38:18Z", "timestamp": 1574865498143}, "reference-count": 141, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2018, 8, 14]], "date-time": "2018-08-14T00:00:00Z", "timestamp": 1534204800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Clinic Rev Allerg Immunol"], "published-print": {"date-parts": [[2018, 12]]}, "DOI": "10.1007/s12016-018-8702-3", "type": "journal-article", "created": {"date-parts": [[2018, 8, 14]], "date-time": "2018-08-14T21:58:38Z", "timestamp": 1534283918000}, "page": "379-390", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 27, "title": ["The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis"], "prefix": "10.1007", "volume": "55", "author": [{"given": "Andrew", "family": "Blauvelt", "sequence": "first", "affiliation": []}, {"given": "Andrea", "family": "Chiricozzi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 8, 14]]}, "reference": [{"key": "8702_CR1", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1146/annurev-immunol-032713-120225", "volume": "32", "author": "MA Lowes", "year": "2014", "unstructured": "Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32:227\u2013255. \n                    https://doi.org/10.1146/annurev-immunol-032713-120225", "journal-title": "Annu Rev Immunol"}, {"key": "8702_CR2", "doi-asserted-by": "publisher", "first-page": "496", "DOI": "10.1056/NEJMra0804595", "volume": "361", "author": "FO Nestle", "year": "2009", "unstructured": "Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496\u2013509. \n                    https://doi.org/10.1056/NEJMra0804595", "journal-title": "N Engl J Med"}, {"key": "8702_CR3", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1016/S0140-6736(14)61909-7", "volume": "386", "author": "WH Boehncke", "year": "2015", "unstructured": "Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. Lancet 386:983\u2013994. \n                    https://doi.org/10.1016/S0140-6736(14)61909-7", "journal-title": "Lancet"}, {"key": "8702_CR4", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1016/j.molimm.2014.12.014", "volume": "64", "author": "A Chandra", "year": "2015", "unstructured": "Chandra A, Ray A, Senapati S, Chatterjee R (2015) Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol 64:313\u2013323. \n                    https://doi.org/10.1016/j.molimm.2014.12.014", "journal-title": "Mol Immunol"}, {"key": "8702_CR5", "doi-asserted-by": "publisher", "first-page": "677", "DOI": "10.1038/jid.2010.340", "volume": "131", "author": "A Chiricozzi", "year": "2011", "unstructured": "Chiricozzi A, Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M, Nograles KE, Tian S, Cardinale I, Chimenti S, Krueger JG (2011) Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131:677\u2013687", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR6", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1038/jid.2012.194", "volume": "133", "author": "DA Martin", "year": "2013", "unstructured": "Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB (2013) The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 133:17\u201326. \n                    https://doi.org/10.1038/jid.2012.194", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR7", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1007/s13317-013-0057-4", "volume": "5", "author": "B Marinoni", "year": "2014", "unstructured": "Marinoni B, Ceribelli A, Massarotti MS, Selmi C (2014) The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications. Auto Immun Highlights 5:9\u201319. \n                    https://doi.org/10.1007/s13317-013-0057-4", "journal-title": "Auto Immun Highlights"}, {"key": "8702_CR8", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1111/bjd.14034", "volume": "174", "author": "A Chiricozzi", "year": "2016", "unstructured": "Chiricozzi A, Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Cueto I, Li K, Tian S, Brodmerkel C, Krueger JG (2016) Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. Br J Dermatol 174:136\u2013145. \n                    https://doi.org/10.1111/bjd.14034", "journal-title": "Br J Dermatol"}, {"key": "8702_CR9", "doi-asserted-by": "publisher", "first-page": "2990", "DOI": "10.1038/jid.2014.268", "volume": "134", "author": "CQ Wang", "year": "2014", "unstructured": "Wang CQ, Suarez-Farinas M, Nograles KE, Mimoso CA, Shrom D, Dow ER, Heffernan MP, Hoffman RW, Krueger JG (2014) IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood. J Invest Dermatol 134:2990\u20132993. \n                    https://doi.org/10.1038/jid.2014.268", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR10", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1111/imm.12142", "volume": "141", "author": "BW Kirkham", "year": "2014", "unstructured": "Kirkham BW, Kavanaugh A, Reich K (2014) Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology 141:133\u2013142. \n                    https://doi.org/10.1111/imm.12142", "journal-title": "Immunology"}, {"key": "8702_CR11", "doi-asserted-by": "publisher", "first-page": "1373", "DOI": "10.1038/jid.2009.399", "volume": "130", "author": "S Kagami", "year": "2010", "unstructured": "Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373\u20131383. \n                    https://doi.org/10.1038/jid.2009.399", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR12", "doi-asserted-by": "publisher", "first-page": "934", "DOI": "10.1002/art.38995", "volume": "67", "author": "J Belasco", "year": "2015", "unstructured": "Belasco J, Louie JS, Gulati N, Wei N, Nograles K, Fuentes-Duculan J, Mitsui H, Su\u00e1rez-Fari\u00f1as M, Krueger JG (2015) Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis. Arthritis Rheumatol 67:934\u2013944. \n                    https://doi.org/10.1002/art.38995", "journal-title": "Arthritis Rheumatol"}, {"key": "8702_CR13", "doi-asserted-by": "publisher", "first-page": "e90284", "DOI": "10.1371/journal.pone.0090284", "volume": "9", "author": "A Chiricozzi", "year": "2014", "unstructured": "Chiricozzi A, Nograles KE, Johnson-Huang LM, Fuentes-Duculan J, Cardinale I, Bonifacio KM, Gulati N, Mitsui H, Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M, Krueger JG (2014) IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. PLoS One 9:e90284. \n                    https://doi.org/10.1371/journal.pone.0090284", "journal-title": "PLoS One"}, {"key": "8702_CR14", "doi-asserted-by": "publisher", "first-page": "5621", "DOI": "10.1038/ncomms6621", "volume": "5", "author": "R Lande", "year": "2014", "unstructured": "Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S, Vence L, Riccieri V, Guillaume P, Navarini AA, Romero P, Costanzo A, Piccolella E, Gilliet M, Frasca L (2014) The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun 5:5621. \n                    https://doi.org/10.1038/ncomms6621", "journal-title": "Nat Commun"}, {"key": "8702_CR15", "doi-asserted-by": "publisher", "first-page": "2186", "DOI": "10.1084/jem.21213insight3", "volume": "212", "author": "JG Krueger", "year": "2015", "unstructured": "Krueger JG (2015) An autoimmune \u201cattack\u201d on melanocytes triggers psoriasis and cellular hyperplasia. J Exp Med 212:2186. \n                    https://doi.org/10.1084/jem.21213insight3", "journal-title": "J Exp Med"}, {"key": "8702_CR16", "doi-asserted-by": "publisher", "first-page": "2203", "DOI": "10.1084/jem.20151093", "volume": "212", "author": "A Arakawa", "year": "2015", "unstructured": "Arakawa A, Siewert K, St\u00f6hr J, Besgen P, Kim SM, R\u00fchl G, Nickel J, Vollmer S, Thomas P, Krebs S, Pinkert S, Spannagl M, Held K, Kammerbauer C, Besch R, Dornmair K, Prinz JC (2015) Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med 212:2203\u20132212. \n                    https://doi.org/10.1084/jem.20151093", "journal-title": "J Exp Med"}, {"key": "8702_CR17", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1016/j.coi.2011.07.006", "volume": "23", "author": "SL Gaffen", "year": "2011", "unstructured": "Gaffen SL (2011) Recent advances in the IL-17 cytokine family. Curr Opin Immunol 23:613\u2013619. \n                    https://doi.org/10.1016/j.coi.2011.07.006", "journal-title": "Curr Opin Immunol"}, {"key": "8702_CR18", "doi-asserted-by": "publisher", "first-page": "5332", "DOI": "10.1093/emboj/20.19.5332", "volume": "20", "author": "SG Hymowitz", "year": "2001", "unstructured": "Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20:5332\u20135341. \n                    https://doi.org/10.1093/emboj/20.19.5332", "journal-title": "EMBO J"}, {"key": "8702_CR19", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1073/pnas.97.2.773", "volume": "97", "author": "H Li", "year": "2000", "unstructured": "Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, Dowd P, Gurney AL, Wood WI (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A 97:773\u2013778", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "8702_CR20", "doi-asserted-by": "publisher", "first-page": "985", "DOI": "10.1016/S1074-7613(01)00243-6", "volume": "15", "author": "MM Fort", "year": "2001", "unstructured": "Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985\u2013995", "journal-title": "Immunity"}, {"key": "8702_CR21", "doi-asserted-by": "publisher", "first-page": "642", "DOI": "10.4049/jimmunol.169.2.642", "volume": "169", "author": "T Starnes", "year": "2002", "unstructured": "Starnes T, Broxmeyer HE, Robertson MJ, Hromas R (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 169:642\u2013646", "journal-title": "J Immunol"}, {"key": "8702_CR22", "doi-asserted-by": "publisher", "first-page": "1063", "DOI": "10.1084/jem.20071978", "volume": "205", "author": "XO Yang", "year": "2008", "unstructured": "Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, Schluns KS, Broaddus RR, Zhu Z, Dong C (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205:1063\u20131075. \n                    https://doi.org/10.1084/jem.20071978", "journal-title": "J Exp Med"}, {"key": "8702_CR23", "doi-asserted-by": "publisher", "first-page": "611", "DOI": "10.1016/j.immuni.2011.09.010", "volume": "35", "author": "SH Chang", "year": "2011", "unstructured": "Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, Dong C (2011) Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35:611\u2013621. \n                    https://doi.org/10.1016/j.immuni.2011.09.010", "journal-title": "Immunity"}, {"key": "8702_CR24", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1111/j.1365-2133.2008.08902.x", "volume": "160", "author": "C Johansen", "year": "2009", "unstructured": "Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 160:319\u2013324. \n                    https://doi.org/10.1111/j.1365-2133.2008.08902.x", "journal-title": "Br J Dermatol"}, {"key": "8702_CR25", "doi-asserted-by": "publisher", "first-page": "2252", "DOI": "10.4049/jimmunol.1201505", "volume": "190", "author": "A Johnston", "year": "2013", "unstructured": "Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL (2013) Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J Immunol 190:2252\u20132262. \n                    https://doi.org/10.4049/jimmunol.1201505", "journal-title": "J Immunol"}, {"key": "8702_CR26", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1093/intimm/dxw011", "volume": "28", "author": "R Muromoto", "year": "2016", "unstructured": "Muromoto R, Hirao T, Tawa K, Hirashima K, Kon S, Kitai Y, Matsuda T (2016) IL-17A plays a central role in the expression of psoriasis signature genes through the induction of I\u03baB-\u03b6 in keratinocytes. Int Immunol 28:443\u2013452. \n                    https://doi.org/10.1093/intimm/dxw011", "journal-title": "Int Immunol"}, {"key": "8702_CR27", "doi-asserted-by": "publisher", "first-page": "326", "DOI": "10.1056/NEJMoa1314258", "volume": "371", "author": "RG Langley", "year": "2014", "unstructured": "Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C, ERASURE and FIXTURE Study Groups (2014) Secukinumab in plaque psoriasis\u2014results of two phase 3 trials. N Engl J Med 371:326\u2013338. \n                    https://doi.org/10.1056/NEJMoa1314258", "journal-title": "N Engl J Med"}, {"key": "8702_CR28", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1056/NEJMoa1512711", "volume": "375", "author": "KB Gordon", "year": "2016", "unstructured": "Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL, UNCOVER-1, UNCOVER-2, UNCOVER-3 Study Groups (2016) Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis. N Engl J Med 375:345\u2013356. \n                    https://doi.org/10.1056/NEJMoa1512711", "journal-title": "N Engl J Med"}, {"key": "8702_CR29", "doi-asserted-by": "publisher", "first-page": "52ra72", "DOI": "10.1126/scitranslmed.3001107", "volume": "2", "author": "W Hueber", "year": "2010", "unstructured": "Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH, Psoriasis Study G, Durez P, Tak PP, Gomez-Reino JJ, Rheumatoid Arthritis Study G, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD, Uveitis Study G, Rose K, Haider A, Di Padova F (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2:52ra72. \n                    https://doi.org/10.1126/scitranslmed.3001107", "journal-title": "Sci Transl Med"}, {"key": "8702_CR30", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1016/j.jaci.2012.04.024", "volume": "130", "author": "JG Krueger", "year": "2012", "unstructured": "Krueger JG, Fretzin S, Su\u00e1rez-Fari\u00f1as M, Haslett PA, Phipps KM, Cameron GS, McColm J, Katcherian A, Cueto I, White T, Banerjee S, Hoffman RW (2012) IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol 130:145\u2013154", "journal-title": "J Allergy Clin Immunol"}, {"key": "8702_CR31", "doi-asserted-by": "publisher", "first-page": "1022-10.e1", "DOI": "10.1016/j.jaci.2009.08.046", "volume": "124", "author": "LC Zaba", "year": "2009", "unstructured": "Zaba LC, Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG (2009) Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124:1022-10.e1\u20131022-10395. \n                    https://doi.org/10.1016/j.jaci.2009.08.046", "journal-title": "J Allergy Clin Immunol"}, {"key": "8702_CR32", "doi-asserted-by": "publisher", "first-page": "650", "DOI": "10.1038/ni.1613", "volume": "9", "author": "E Volpe", "year": "2008", "unstructured": "Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E, Soumelis V (2008) A critical function for transforming growth factor-\u03b2, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol 9:650\u2013657. \n                    https://doi.org/10.1038/ni.1613", "journal-title": "Nat Immunol"}, {"key": "8702_CR33", "doi-asserted-by": "publisher", "first-page": "34605", "DOI": "10.1074/jbc.M705100200", "volume": "282", "author": "L Wei", "year": "2007", "unstructured": "Wei L, Laurence A, Elias KM, O'Shea JJ (2007) IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 282:34605\u201334610. \n                    https://doi.org/10.1074/jbc.M705100200", "journal-title": "J Biol Chem"}, {"key": "8702_CR34", "doi-asserted-by": "publisher", "first-page": "1339", "DOI": "10.1038/jid.2009.59", "volume": "129", "author": "A Cesare Di", "year": "2009", "unstructured": "Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339\u20131350. \n                    https://doi.org/10.1038/jid.2009.59", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR35", "doi-asserted-by": "publisher", "first-page": "5948", "DOI": "10.4049/jimmunol.181.9.5948", "volume": "181", "author": "GL Stritesky", "year": "2008", "unstructured": "Stritesky GL, Yeh N, Kaplan MH (2008) IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol 181:5948\u20135955", "journal-title": "J Immunol"}, {"key": "8702_CR36", "first-page": "169", "volume": "20", "author": "M Mortezavi", "year": "2015", "unstructured": "Mortezavi M, Ritchlin C (2015) Immunologic advances reveal new targets in psoriasis and psoriatic arthritis. Discov Med 20:169\u2013175", "journal-title": "Discov Med"}, {"key": "8702_CR37", "doi-asserted-by": "publisher", "first-page": "R136", "DOI": "10.1186/ar4317", "volume": "15", "author": "H Benham", "year": "2013", "unstructured": "Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, Smith M, Thomas R, Gaston H (2013) Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther 15:R136. \n                    https://doi.org/10.1186/ar4317", "journal-title": "Arthritis Res Ther"}, {"key": "8702_CR38", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1186/s13075-017-1249-5", "volume": "19", "author": "SP Raychaudhuri", "year": "2017", "unstructured": "Raychaudhuri SP, Raychaudhuri SK (2017) Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther 19:51. \n                    https://doi.org/10.1186/s13075-017-1249-5", "journal-title": "Arthritis Res Ther"}, {"key": "8702_CR39", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1016/j.jdermsci.2016.10.007", "volume": "85", "author": "A Ueyama", "year": "2017", "unstructured": "Ueyama A, Imura C, Fusamae Y, Tsujii K, Furue Y, Aoki M, Suzuki M, Okuda T, Oshima I, Yasui K, Shichijo M, Yamamoto M (2017) Potential role of IL-17-producing CD4/CD8 double negative \u03b1\u03b2 T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model. J Dermatol Sci 85:27\u201335. \n                    https://doi.org/10.1016/j.jdermsci.2016.10.007", "journal-title": "J Dermatol Sci"}, {"key": "8702_CR40", "doi-asserted-by": "publisher", "first-page": "490", "DOI": "10.4049/jimmunol.1100123", "volume": "187", "author": "AM Lin", "year": "2011", "unstructured": "Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, Villanueva EC, Shah P, Kaplan MJ, Bruce AT (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187:490\u2013500. \n                    https://doi.org/10.4049/jimmunol.1100123", "journal-title": "J Immunol"}, {"key": "8702_CR41", "doi-asserted-by": "publisher", "first-page": "1276", "DOI": "10.1038/jid.2013.526", "volume": "134", "author": "RR Keijsers", "year": "2014", "unstructured": "Keijsers RR, Hendriks AG, van Erp PE, van Cranenbroek B, van de Kerkhof PC, Koenen HJ, Joosten I (2014) In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing ROR\u03b3t and IL-17. J Invest Dermatol 134:1276\u20131284. \n                    https://doi.org/10.1038/jid.2013.526", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR42", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1016/j.jaci.2015.01.033", "volume": "136", "author": "S Mashiko", "year": "2015", "unstructured": "Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M (2015) Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol 136:351\u2013359 e351. \n                    https://doi.org/10.1016/j.jaci.2015.01.033", "journal-title": "J Allergy Clin Immunol"}, {"key": "8702_CR43", "doi-asserted-by": "publisher", "first-page": "2673", "DOI": "10.1002/art.39261", "volume": "67", "author": "EF Leijten", "year": "2015", "unstructured": "Leijten EF, van Kempen TS, Boes M, Michels-van Amelsfort JM, Hijnen D, Hartgring SA, van Roon JA, Wenink MH, Radstake TR (2015) Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid. Arthritis Rheumatol 67:2673\u20132678. \n                    https://doi.org/10.1002/art.39261", "journal-title": "Arthritis Rheumatol"}, {"key": "8702_CR44", "doi-asserted-by": "publisher", "first-page": "609", "DOI": "10.1111/bjd.12658", "volume": "170", "author": "B Dyring-Andersen", "year": "2014", "unstructured": "Dyring-Andersen B, Geisler C, Agerbeck C, Lauritsen JP, G\u00fadjonsdottir SD, Skov L, Bonefeld CM (2014) Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 170:609\u2013616. \n                    https://doi.org/10.1111/bjd.12658", "journal-title": "Br J Dermatol"}, {"key": "8702_CR45", "doi-asserted-by": "publisher", "first-page": "984", "DOI": "10.1038/jid.2013.477", "volume": "134", "author": "F Villanova", "year": "2014", "unstructured": "Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, Chapman A, Smith CH, Di Meglio P, Nestle FO (2014) Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134:984\u2013991. \n                    https://doi.org/10.1038/jid.2013.477", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR46", "doi-asserted-by": "publisher", "first-page": "205156", "DOI": "10.1155/2015/205156", "volume": "2015", "author": "J Bystrom", "year": "2015", "unstructured": "Bystrom J, Taher TE, Muhyaddin MS, Clanchy FI, Mangat P, Jawad AS, Williams RO, Mageed RA (2015) Harnessing the therapeutic potential of Th17 cells. Mediat Inflamm 2015:205156\u2013205111. \n                    https://doi.org/10.1155/2015/205156", "journal-title": "Mediat Inflamm"}, {"key": "8702_CR47", "doi-asserted-by": "publisher", "first-page": "799", "DOI": "10.1111/exd.12487", "volume": "23", "author": "RR Keijsers", "year": "2014", "unstructured": "Keijsers RR, Joosten I, van Erp PE, Koenen HJ, van de Kerkhof PC (2014) Cellular sources of IL-17 in psoriasis: a paradigm shift? Exp Dermatol 23:799\u2013803. \n                    https://doi.org/10.1111/exd.12487", "journal-title": "Exp Dermatol"}, {"key": "8702_CR48", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1111/exd.12710", "volume": "24", "author": "K Reich", "year": "2015", "unstructured": "Reich K, Papp KA, Matheson RT, Tu JH, Bissonnette R, Bourcier M, Gratton D, Kunynetz RA, Poulin Y, Rosoph LA, Stingl G, Bauer WM, Salter JM, Falk TM, Bl\u00f6dorn-Schlicht NA, Hueber W, Sommer U, Schumacher MM, Peters T, Kriehuber E, Lee DM, Wieczorek GA, Kolbinger F, Bleul CC (2015) Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis. Exp Dermatol 24:529\u2013535. \n                    https://doi.org/10.1111/exd.12710", "journal-title": "Exp Dermatol"}, {"key": "8702_CR49", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1016/j.imlet.2014.10.025", "volume": "162", "author": "F Tamarozzi", "year": "2014", "unstructured": "Tamarozzi F, Wright HL, Thomas HB, Edwards SW, Taylor MJ (2014) A lack of confirmation with alternative assays questions the validity of IL-17A expression in human neutrophils using immunohistochemistry. Immunol Lett 162:194\u2013198. \n                    https://doi.org/10.1016/j.imlet.2014.10.025", "journal-title": "Immunol Lett"}, {"key": "8702_CR50", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.3389/fimmu.2018.00795", "volume": "9", "author": "N Tamassia", "year": "2018", "unstructured": "Tamassia N, Arruda-Silva F, Calzetti F, Lonardi S, Gasperini S, Gardiman E, Bianchetto-Aguilera F, Gatta LB, Girolomoni G, Mantovani A, Vermi W, Cassatella MA (2018) A reappraisal on the potential ability of human neutrophils to express and produce IL-17 family members in vitro: failure to reproducibly detect it. Front Immunol 9:795. \n                    https://doi.org/10.3389/fimmu.2018.00795", "journal-title": "Front Immunol"}, {"key": "8702_CR51", "doi-asserted-by": "publisher", "first-page": "e12952", "DOI": "10.1111/eci.12952", "volume": "48", "author": "Nicola Tamassia", "year": "2018", "unstructured": "Tamassia N, Bianchetto-Aguilera F, Arruda-Silva F, Gardiman E, Gasperini S, Calzetti F, Cassatella MA (2018) Cytokine production by human neutrophils: revisiting the \u201cdark side of the moon\u201d. Eur J Clin Invest:e12952. \n                    https://doi.org/10.1111/eci.12952", "journal-title": "European Journal of Clinical Investigation"}, {"key": "8702_CR52", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1111/exd.13067", "volume": "26", "author": "MP Sch\u00f6n", "year": "2017", "unstructured": "Sch\u00f6n MP, Broekaert SM, Erpenbeck L (2017) Sexy again: the renaissance of neutrophils in psoriasis. Exp Dermatol 26:305\u2013311. \n                    https://doi.org/10.1111/exd.13067", "journal-title": "Exp Dermatol"}, {"key": "8702_CR53", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1038/ni.2797", "volume": "15", "author": "PR Taylor", "year": "2014", "unstructured": "Taylor PR, Roy S, Leal SM Jr, Sun Y, Howell SJ, Cobb BA, Li X, Pearlman E (2014) Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, ROR\u03b3t and dectin-2. Nat Immunol 15:143\u2013151. \n                    https://doi.org/10.1038/ni.2797", "journal-title": "Nat Immunol"}, {"key": "8702_CR54", "doi-asserted-by": "publisher", "first-page": "e321", "DOI": "10.1111/bjd.15533", "volume": "177", "author": "B Dyring-Andersen", "year": "2017", "unstructured": "Dyring-Andersen B, Honor\u00e9 TV, Madelung A, Bzorek M, Simonsen S, Clemmensen SN, Clark RA, Borregaard N, Skov L (2017) Interleukin (IL)-17A and IL-22-producing neutrophils in psoriatic skin. Br J Dermatol 177:e321\u2013e322. \n                    https://doi.org/10.1111/bjd.15533", "journal-title": "Br J Dermatol"}, {"key": "8702_CR55", "doi-asserted-by": "publisher", "first-page": "1883", "DOI": "10.1002/eji.201040994", "volume": "41", "author": "A Dudeck", "year": "2011", "unstructured": "Dudeck A, Suender CA, Kostka SL, von Stebut E, Maurer M (2011) Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur J Immunol 41:1883\u20131893. \n                    https://doi.org/10.1002/eji.201040994", "journal-title": "Eur J Immunol"}, {"key": "8702_CR56", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1189/jlb.3HI1215-542R", "volume": "100", "author": "T Noordenbos", "year": "2016", "unstructured": "Noordenbos T, Blijdorp I, Chen S, Stap J, Mul E, Ca\u00f1ete JD, Lubberts E, Yeremenko N, Baeten D (2016) Human mast cells capture, store, and release bioactive, exogenous IL-17A. J Leukoc Biol 100:453\u2013462. \n                    https://doi.org/10.1189/jlb.3HI1215-542R", "journal-title": "J Leukoc Biol"}, {"key": "8702_CR57", "doi-asserted-by": "publisher", "first-page": "375", "DOI": "10.1007/s11926-012-0257-3", "volume": "14", "author": "RJ Lories", "year": "2012", "unstructured": "Lories RJ, de Vlam K (2012) Is psoriatic arthritis a result of abnormalities in acquired or innate immunity? Curr Rheumatol Rep 14:375\u2013382. \n                    https://doi.org/10.1007/s11926-012-0257-3", "journal-title": "Curr Rheumatol Rep"}, {"issue": "2", "key": "8702_CR58", "doi-asserted-by": "publisher", "first-page": "530", "DOI": "10.3390/ijms19020530", "volume": "19", "author": "Marie-Astrid Boutet", "year": "2018", "unstructured": "Boutet MA, Nerviani A, Gallo Afflitto G, Pitzalis C (2018) Role of the IL-23/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints. Int J Mol Sci 19. \n                    https://doi.org/10.3390/ijms19020530", "journal-title": "International Journal of Molecular Sciences"}, {"key": "8702_CR59", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1016/j.autrev.2016.09.015", "volume": "16", "author": "LI Sakkas", "year": "2017", "unstructured": "Sakkas LI, Bogdanos DP (2017) Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data. Autoimmun Rev 16:10\u201315. \n                    https://doi.org/10.1016/j.autrev.2016.09.015", "journal-title": "Autoimmun Rev"}, {"key": "8702_CR60", "doi-asserted-by": "publisher", "first-page": "496", "DOI": "10.1016/j.autrev.2014.01.050", "volume": "13", "author": "E Suzuki", "year": "2014", "unstructured": "Suzuki E, Mellins ED, Gershwin ME, Nestle FO, Adamopoulos IE (2014) The IL-23/IL-17 axis in psoriatic arthritis. Autoimmun Rev 13:496\u2013502. \n                    https://doi.org/10.1016/j.autrev.2014.01.050", "journal-title": "Autoimmun Rev"}, {"key": "8702_CR61", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1002/art.33396", "volume": "64", "author": "T Noordenbos", "year": "2012", "unstructured": "Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, Ca\u0148ete JD, Baeten D (2012) Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum 64:99\u2013109. \n                    https://doi.org/10.1002/art.33396", "journal-title": "Arthritis Rheum"}, {"key": "8702_CR62", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1002/path.2667", "volume": "220", "author": "OJ Boer de", "year": "2010", "unstructured": "de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, Idu MM, van Maldegem F, Aten J, van der Wal AC (2010) Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J Pathol 220:499\u2013508. \n                    https://doi.org/10.1002/path.2667", "journal-title": "J Pathol"}, {"key": "8702_CR63", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1111/cei.12853", "volume": "186", "author": "G Guggino", "year": "2016", "unstructured": "Guggino G, Ciccia F, Di Liberto D, Lo Pizzo M, Ruscitti P, Cipriani P, Ferrante A, Sireci G, Dieli F, Fournie JJ, Giacomelli R, Triolo G (2016) Interleukin (IL)-9/IL-9R axis drives \u03b3\u03b4 T cells activation in psoriatic arthritis patients. Clin Exp Immunol 186:277\u2013283. \n                    https://doi.org/10.1111/cei.12853", "journal-title": "Clin Exp Immunol"}, {"key": "8702_CR64", "doi-asserted-by": "publisher", "first-page": "596", "DOI": "10.1016/j.immuni.2011.08.001", "volume": "35", "author": "Y Cai", "year": "2011", "unstructured": "Cai Y, Shen X, Ding C, Qi C, Li K, Li X, Jala VR, Zhang HG, Wang T, Zheng J, Yan J (2011) Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation. Immunity 35:596\u2013610", "journal-title": "Immunity"}, {"key": "8702_CR65", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1016/j.cellimm.2015.01.011", "volume": "296", "author": "RL O'Brien", "year": "2015", "unstructured": "O'Brien RL, Born WK (2015) Dermal \u03b3\u03b4 T cells\u2014what have we learned? Cell Immunol 296:62\u201369. \n                    https://doi.org/10.1016/j.cellimm.2015.01.011", "journal-title": "Cell Immunol"}, {"key": "8702_CR66", "doi-asserted-by": "publisher", "first-page": "426", "DOI": "10.1186/s13075-014-0426-z", "volume": "16", "author": "LG Baarsen van", "year": "2014", "unstructured": "van Baarsen LG, Lebre MC, van der Coelen D, Aarrass S, Tang MW, Ramwadhdoebe TH, Gerlag DM, Tak PP (2014) Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? Arthritis Res Ther 16:426. \n                    https://doi.org/10.1186/s13075-014-0426-z", "journal-title": "Arthritis Res Ther"}, {"key": "8702_CR67", "doi-asserted-by": "publisher", "first-page": "3022", "DOI": "10.1002/eji.201545883", "volume": "45", "author": "T Hartwig", "year": "2015", "unstructured": "Hartwig T, Pantelyushin S, Croxford AL, Kulig P, Becher B (2015) Dermal IL-17-producing \u03b3\u03b4 T cells establish long-lived memory in the skin. Eur J Immunol 45:3022\u20133033. \n                    https://doi.org/10.1002/eji.201545883", "journal-title": "Eur J Immunol"}, {"key": "8702_CR68", "doi-asserted-by": "publisher", "first-page": "5026", "DOI": "10.4049/jimmunol.1101817", "volume": "187", "author": "T Mabuchi", "year": "2011", "unstructured": "Mabuchi T, Takekoshi T, Hwang ST (2011) Epidermal CCR6+ \u03b3\u03b4 T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol 187:5026\u20135031. \n                    https://doi.org/10.4049/jimmunol.1101817", "journal-title": "J Immunol"}, {"key": "8702_CR69", "doi-asserted-by": "publisher", "first-page": "e14108", "DOI": "10.1371/journal.pone.0014108", "volume": "5", "author": "PC Res", "year": "2010", "unstructured": "Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, Teunissen MB (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One 5:e14108. \n                    https://doi.org/10.1371/journal.pone.0014108", "journal-title": "PLoS One"}, {"key": "8702_CR70", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1189/JLB.0109046", "volume": "86", "author": "C Ortega", "year": "2009", "unstructured": "Ortega C, Fern\u00e1ndez-A S, Carrillo JM, Romero P, Molina IJ, Moreno JC, Santamaria M (2009) IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol 86:435\u2013443. \n                    https://doi.org/10.1189/JLB.0109046", "journal-title": "J Leukoc Biol"}, {"key": "8702_CR71", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1038/jid.2012.456", "volume": "133", "author": "D Hijnen", "year": "2013", "unstructured": "Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, Bruijnzeel-Koomen CA, Clark RA (2013) CD8+ T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-\u0263, IL-13, IL-17, and IL-22. J Invest Dermatol 133:973\u2013979. \n                    https://doi.org/10.1038/jid.2012.456", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR72", "doi-asserted-by": "publisher", "first-page": "1207", "DOI": "10.1038/sj.jid.5701213", "volume": "128", "author": "MA Lowes", "year": "2008", "unstructured": "Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207\u20131211. \n                    https://doi.org/10.1038/sj.jid.5701213", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR73", "doi-asserted-by": "publisher", "first-page": "2175", "DOI": "10.1038/jid.2009.65", "volume": "129", "author": "EG Harper", "year": "2009", "unstructured": "Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M, Blauvelt A (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129:2175\u20132183. \n                    https://doi.org/10.1038/jid.2009.65", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR74", "doi-asserted-by": "publisher", "first-page": "164", "DOI": "10.1038/jid.2012.260", "volume": "133", "author": "T Mabuchi", "year": "2013", "unstructured": "Mabuchi T, Singh TP, Takekoshi T, Jia GF, Wu X, Kao MC, Weiss I, Farber JM, Hwang ST (2013) CCR6 is required for epidermal trafficking of \u03b3\u03b4-T cells in an IL-23-induced model of psoriasiform dermatitis. J Invest Dermatol 133:164\u2013171. \n                    https://doi.org/10.1038/jid.2012.260", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR75", "doi-asserted-by": "publisher", "first-page": "1462", "DOI": "10.1038/jid.2013.534", "volume": "134", "author": "TG Kim", "year": "2014", "unstructured": "Kim TG, Jee H, Fuentes-Duculan J, Wu WH, Byamba D, Kim DS, Kim DY, Lew DH, Yang WI, Krueger JG, Lee MG (2014) Dermal clusters of mature dendritic cells and T cells are associated with the CCL20/CCR6 chemokine system in chronic psoriasis. J Invest Dermatol 134:1462\u20131465. \n                    https://doi.org/10.1038/jid.2013.534", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR76", "doi-asserted-by": "publisher", "first-page": "911", "DOI": "10.1517/14728222.2010.504716", "volume": "14", "author": "MN Hedrick", "year": "2010", "unstructured": "Hedrick MN, Lonsdorf AS, Hwang ST, Farber JM (2010) CCR6 as a possible therapeutic target in psoriasis. Expert Opin Ther Targets 14:911\u2013922. \n                    https://doi.org/10.1517/14728222.2010.504716", "journal-title": "Expert Opin Ther Targets"}, {"key": "8702_CR77", "doi-asserted-by": "publisher", "first-page": "2317", "DOI": "10.1172/JCI37378", "volume": "119", "author": "MN Hedrick", "year": "2009", "unstructured": "Hedrick MN, Lonsdorf AS, Shirakawa AK, Richard Lee CC, Liao F, Singh SP, Zhang HH, Grinberg A, Love PE, Hwang ST, Farber JM (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119:2317\u20132329", "journal-title": "J Clin Invest"}, {"key": "8702_CR78", "doi-asserted-by": "publisher", "first-page": "2305", "DOI": "10.1038/jid.2014.216", "volume": "134", "author": "NL Ward", "year": "2014", "unstructured": "Ward NL, Umetsu DT (2014) A new player on the psoriasis block: IL-17A- and IL-22-producing innate lymphoid cells. J Invest Dermatol 134:2305\u20132307. \n                    https://doi.org/10.1038/jid.2014.216", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR79", "doi-asserted-by": "publisher", "first-page": "2351", "DOI": "10.1038/jid.2014.146", "volume": "134", "author": "MBM Teunissen", "year": "2014", "unstructured": "Teunissen MBM, Munneke JM, Bernink JH, Spuls PI, Res PCM, Te Velde A, Cheuk S, Brouwer MWD, Menting SP, Eidsmo L, Spits H, Hazenberg MD, Mj\u00f6sberg J (2014) Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR+ ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 134:2351\u20132360. \n                    https://doi.org/10.1038/jid.2014.146", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR80", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1016/j.chom.2012.10.003", "volume": "12", "author": "ED Tait Wojno", "year": "2012", "unstructured": "Tait Wojno ED, Artis D (2012) Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 12:445\u2013457. \n                    https://doi.org/10.1016/j.chom.2012.10.003", "journal-title": "Cell Host Microbe"}, {"key": "8702_CR81", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1111/bjd.12937", "volume": "171", "author": "A Johnston", "year": "2014", "unstructured": "Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE (2014) Early tissue responses in psoriasis to the antitumour necrosis factor-\u03b1 biologic etanercept suggest reduced interleukin-17 receptor expression and signalling. Br J Dermatol 171:97\u2013107. \n                    https://doi.org/10.1111/bjd.12937", "journal-title": "Br J Dermatol"}, {"key": "8702_CR82", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.4049/jimmunol.1001001", "volume": "186", "author": "HL Rizzo", "year": "2011", "unstructured": "Rizzo HL, Kagami S, Phillips KG, Kurtz SE, Jacques SL, Blauvelt A (2011) IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J Immunol 186:1495\u20131502. \n                    https://doi.org/10.4049/jimmunol.1001001", "journal-title": "J Immunol"}, {"key": "8702_CR83", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1080/1744666X.2017.1292137", "volume": "13", "author": "L Puig", "year": "2017", "unstructured": "Puig L (2017) The role of IL 23 in the treatment of psoriasis. Expert Rev Clin Immunol 13:525\u2013534. \n                    https://doi.org/10.1080/1744666X.2017.1292137", "journal-title": "Expert Rev Clin Immunol"}, {"key": "8702_CR84", "doi-asserted-by": "publisher", "first-page": "461", "DOI": "10.1007/s11926-007-0075-1", "volume": "9", "author": "E Fitch", "year": "2007", "unstructured": "Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461\u2013467", "journal-title": "Curr Rheumatol Rep"}, {"key": "8702_CR85", "doi-asserted-by": "publisher", "first-page": "1079", "DOI": "10.1084/jem.20170369", "volume": "215", "author": "AJ St Leger", "year": "2018", "unstructured": "St Leger AJ, Hansen AM, Karauzum H, Horai R, Yu CR, Laurence A, Mayer-Barber KD, Silver P, Villasmil R, Egwuagu C, Datta SK, Caspi RR (2018) STAT-3-independent production of IL-17 by mouse innate-like alpha\u03b2 T cells controls ocular infection. J Exp Med 215:1079\u20131090. \n                    https://doi.org/10.1084/jem.20170369", "journal-title": "J Exp Med"}, {"key": "8702_CR86", "first-page": "369", "volume": "22", "author": "Y Yoshiga", "year": "2008", "unstructured": "Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S, Tsutsumi A, Taniguchi M, Sumida T (2008) Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int J Mol Med 22:369\u2013374", "journal-title": "Int J Mol Med"}, {"key": "8702_CR87", "doi-asserted-by": "publisher", "first-page": "763", "DOI": "10.1038/nrd3794", "volume": "11", "author": "P Miossec", "year": "2012", "unstructured": "Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763\u2013776. \n                    https://doi.org/10.1038/nrd3794", "journal-title": "Nat Rev Drug Discov"}, {"key": "8702_CR88", "doi-asserted-by": "publisher", "first-page": "142", "DOI": "10.1111/prd.12083", "volume": "69", "author": "C Zenobia", "year": "2015", "unstructured": "Zenobia C, Hajishengallis G (2015) Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 69:142\u2013159. \n                    https://doi.org/10.1111/prd.12083", "journal-title": "Periodontol"}, {"key": "8702_CR89", "doi-asserted-by": "publisher", "first-page": "993", "DOI": "10.1517/13543784.2013.806483", "volume": "22", "author": "A Chiricozzi", "year": "2013", "unstructured": "Chiricozzi A, Krueger JG (2013) IL-17 targeted therapies for psoriasis. Expert Opin Investig Drugs 22:993\u20131005. \n                    https://doi.org/10.1517/13543784.2013.806483", "journal-title": "Expert Opin Investig Drugs"}, {"key": "8702_CR90", "doi-asserted-by": "publisher", "first-page": "4344", "DOI": "10.4049/jimmunol.1400181", "volume": "193", "author": "C Erbel", "year": "2014", "unstructured": "Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, Stellos K, Little KM, Lasitschka F, Doesch A, Hakimi M, Dengler TJ, Giese T, Blessing E, Katus HA, Gleissner CA (2014) IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis. J Immunol 193:4344\u20134355. \n                    https://doi.org/10.4049/jimmunol.1400181", "journal-title": "J Immunol"}, {"key": "8702_CR91", "doi-asserted-by": "publisher", "first-page": "1665", "DOI": "10.1016/S0140-6736(08)60725-4", "volume": "371", "author": "CL Leonardi", "year": "2008", "unstructured": "Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, Li S, Dooley LT, Gordon KB, Phoenix Study Investigators (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665\u20131674. \n                    https://doi.org/10.1016/S0140-6736(08)60725-4", "journal-title": "Lancet"}, {"key": "8702_CR92", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1016/j.jaad.2016.11.041", "volume": "76", "author": "A Blauvelt", "year": "2017", "unstructured": "Blauvelt A, Papp KA, Griffiths CE, Randazzo B, Wasfi Y, Shen YK, Li S, Kimball AB (2017) Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial. J Am Acad Dermatol 76:405\u2013417. \n                    https://doi.org/10.1016/j.jaad.2016.11.041", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR93", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1016/S0140-6736(17)31279-5", "volume": "390", "author": "K Reich", "year": "2017", "unstructured": "Reich K, Papp KA, Blauvelt A, Tyring SK, Sinclair R, Tha\u00e7i D, Nograles K, Mehta A, Cichanowitz N, Li Q, Liu K, La Rosa C, Green S, Kimball AB (2017) Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. Lancet 390:276\u2013288. \n                    https://doi.org/10.1016/S0140-6736(17)31279-5", "journal-title": "Lancet"}, {"key": "8702_CR94", "doi-asserted-by": "publisher", "first-page": "1551", "DOI": "10.1056/NEJMoa1607017", "volume": "376", "author": "KA Papp", "year": "2017", "unstructured": "Papp KA, Blauvelt A, Bukhalo M, Gooderham M, Krueger JG, Lacour JP, Menter A, Philipp S, Sofen H, Tyring S, Berner BR, Visvanathan S, Pamulapati C, Bennett N, Flack M, Scholl P, Padula SJ (2017) Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis. N Engl J Med 376:1551\u20131560. \n                    https://doi.org/10.1056/NEJMoa1607017", "journal-title": "N Engl J Med"}, {"key": "8702_CR95", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1016/S0140-6736(15)60125-8", "volume": "386", "author": "CE Griffiths", "year": "2015", "unstructured": "Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K, UNCOVER-2 and UNCOVER-3 Investigators (2015) Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386:541\u2013551. \n                    https://doi.org/10.1016/S0140-6736(15)60125-8", "journal-title": "Lancet"}, {"key": "8702_CR96", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1016/j.jaad.2018.03.037", "volume": "79", "author": "KA Papp", "year": "2018", "unstructured": "Papp KA, Merola JF, Gottlieb AB, Griffiths CEM, Cross N, Peterson L, Cioffi C, Blauvelt A (2018) Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial. J Am Acad Dermatol 79:277\u2013286. \n                    https://doi.org/10.1016/j.jaad.2018.03.037", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR97", "doi-asserted-by": "publisher", "first-page": "1318", "DOI": "10.1056/NEJMoa1503824", "volume": "373", "author": "M Lebwohl", "year": "2015", "unstructured": "Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A (2015) Phase 3 studies comparing brodalumab with ustekinumab in psoriasis. N Engl J Med 373:1318\u20131328. \n                    https://doi.org/10.1056/NEJMoa1503824", "journal-title": "N Engl J Med"}, {"key": "8702_CR98", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1111/dth.12251", "volume": "28", "author": "AA Gaspari", "year": "2015", "unstructured": "Gaspari AA, Tyring S (2015) New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors. Dermatol Ther 28:179\u2013193. \n                    https://doi.org/10.1111/dth.12251", "journal-title": "Dermatol Ther"}, {"key": "8702_CR99", "doi-asserted-by": "publisher", "first-page": "1946", "DOI": "10.1038/jid.2015.144", "volume": "135", "author": "A Blauvelt", "year": "2015", "unstructured": "Blauvelt A, Lebwohl MG, Bissonnette R (2015) IL-23/IL-17A dysfunction phenotypes inform possible clinical effects from anti-IL-17A therapies. J Invest Dermatol 135:1946\u20131953. \n                    https://doi.org/10.1038/jid.2015.144", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR100", "doi-asserted-by": "publisher", "first-page": "1616", "DOI": "10.1111/jdv.14433", "volume": "31", "author": "G Girolomoni", "year": "2017", "unstructured": "Girolomoni G, Strohal R, Puig L, Bachelez H, Barker J, Boehncke WH, Prinz JC (2017) The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol 31:1616\u20131626. \n                    https://doi.org/10.1111/jdv.14433", "journal-title": "J Eur Acad Dermatol Venereol"}, {"key": "8702_CR101", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1007/s13555-017-0187-0", "volume": "7", "author": "M Nakamura", "year": "2017", "unstructured": "Nakamura M, Lee K, Jeon C, Sekhon S, Afifi L, Yan D, Lee K, Bhutani T (2017) Guselkumab for the treatment of psoriasis: a review of phase III trials. Dermatol Ther (Heidelb) 7:281\u2013292. \n                    https://doi.org/10.1007/s13555-017-0187-0", "journal-title": "Dermatol Ther (Heidelb)"}, {"key": "8702_CR102", "doi-asserted-by": "publisher", "first-page": "603", "DOI": "10.1038/ni.1736", "volume": "10", "author": "W O'Connor Jr", "year": "2009", "unstructured": "O'Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10:603\u2013609. \n                    https://doi.org/10.1038/ni.1736", "journal-title": "Nat Immunol"}, {"key": "8702_CR103", "doi-asserted-by": "publisher", "first-page": "1693", "DOI": "10.1136/gutjnl-2011-301668", "volume": "61", "author": "W Hueber", "year": "2012", "unstructured": "Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP, Secukinumab in Crohn\u2019s Disease Study Group (2012) Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61:1693\u20131700. \n                    https://doi.org/10.1136/gutjnl-2011-301668", "journal-title": "Gut"}, {"key": "8702_CR104", "doi-asserted-by": "publisher", "first-page": "3255", "DOI": "10.3748/wjg.v20.i12.3255", "volume": "20", "author": "XR Xu", "year": "2014", "unstructured": "Xu XR, Liu CQ, Feng BS, Liu ZJ (2014) Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol 20:3255\u20133264. \n                    https://doi.org/10.3748/wjg.v20.i12.3255", "journal-title": "World J Gastroenterol"}, {"key": "8702_CR105", "doi-asserted-by": "publisher", "first-page": "1599", "DOI": "10.1038/ajg.2016.298", "volume": "111", "author": "SR Targan", "year": "2016", "unstructured": "Targan SR, Feagan B, Vermeire S, Panaccione R, Melmed GY, Landers C, Li D, Russell C, Newmark R, Zhang N, Chon Y, Hsu YH, Lin SL, Klekotka P (2016) A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn's disease. Am J Gastroenterol 111:1599\u20131607. \n                    https://doi.org/10.1038/ajg.2016.298", "journal-title": "Am J Gastroenterol"}, {"key": "8702_CR106", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1016/j.immuni.2015.09.003", "volume": "43", "author": "JS Lee", "year": "2015", "unstructured": "Lee JS, Tato CM, Joyce-Shaikh B, Gulen MF, Cayatte C, Chen Y, Blumenschein WM, Judo M, Ayanoglu G, McClanahan TK, Li X, Cua DJ (2015) Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43:727\u2013738. \n                    https://doi.org/10.1016/j.immuni.2015.09.003", "journal-title": "Immunity"}, {"key": "8702_CR107", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.3389/fimmu.2012.00129", "volume": "3", "author": "AK Marwaha", "year": "2012", "unstructured": "Marwaha AK, Leung NJ, McMurchy AN, Levings MK (2012) TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Front Immunol 3:129. \n                    https://doi.org/10.3389/fimmu.2012.00129", "journal-title": "Front Immunol"}, {"key": "8702_CR108", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1016/j.clim.2013.05.003", "volume": "148", "author": "L Li", "year": "2013", "unstructured": "Li L, Boussiotis VA (2013) The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer. Clin Immunol 148:246\u2013253. \n                    https://doi.org/10.1016/j.clim.2013.05.003", "journal-title": "Clin Immunol"}, {"key": "8702_CR109", "doi-asserted-by": "publisher", "first-page": "1413", "DOI": "10.1080/14740338.2016.1221923", "volume": "15", "author": "A Blauvelt", "year": "2016", "unstructured": "Blauvelt A (2016) Safety of secukinumab in the treatment of psoriasis. Expert Opin Drug Saf 15:1413\u20131420. \n                    https://doi.org/10.1080/14740338.2016.1221923", "journal-title": "Expert Opin Drug Saf"}, {"key": "8702_CR110", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1016/j.jaad.2016.03.024", "volume": "75", "author": "PC Kerkhof van de", "year": "2016", "unstructured": "van de Kerkhof PC, Griffiths CE, Reich K, Leonardi CL, Blauvelt A, Tsai TF, Gong Y, Huang J, Papavassilis C, Fox T (2016) Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis. J Am Acad Dermatol 75:83\u201398.e4. \n                    https://doi.org/10.1016/j.jaad.2016.03.024", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR111", "doi-asserted-by": "publisher", "first-page": "441", "DOI": "10.1016/j.jaad.2016.10.027", "volume": "76", "author": "K Reich", "year": "2017", "unstructured": "Reich K, Leonardi C, Langley RG, Warren RB, Bachelez H, Romiti R, Ohtsuki M, Xu W, Acharya N, Solotkin K, Colombel JF, Hardin DS (2017) Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: a presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials. J Am Acad Dermatol 76:441\u2013448.e2. \n                    https://doi.org/10.1016/j.jaad.2016.10.027", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR112", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1080/09546634.2017.1329511", "volume": "29", "author": "M Hohenberger", "year": "2018", "unstructured": "Hohenberger M, Cardwell LA, Oussedik E, Feldman SR (2018) Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease. J Dermatolog Treat 29:13\u201318. \n                    https://doi.org/10.1080/09546634.2017.1329511", "journal-title": "J Dermatolog Treat"}, {"key": "8702_CR113", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1007/s40257-016-0206-4", "volume": "17", "author": "AW Armstrong", "year": "2016", "unstructured": "Armstrong AW, Bukhalo M, Blauvelt A (2016) A clinician's guide to the diagnosis and treatment of candidiasis in patients with psoriasis. Am J Clin Dermatol 17:329\u2013336. \n                    https://doi.org/10.1007/s40257-016-0206-4", "journal-title": "Am J Clin Dermatol"}, {"key": "8702_CR114", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1016/j.jaad.2017.08.024", "volume": "78", "author": "MG Lebwohl", "year": "2018", "unstructured": "Lebwohl MG, Papp KA, Marangell LB, Koo J, Blauvelt A, Gooderham M, Wu JJ, Rastogi S, Harris S, Pillai R, Israel RJ (2018) Psychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trials. J Am Acad Dermatol 78:81\u201389 e85. \n                    https://doi.org/10.1016/j.jaad.2017.08.024", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR115", "doi-asserted-by": "publisher", "first-page": "e73", "DOI": "10.1016/j.jaad.2017.10.052", "volume": "78", "author": "EA Rieder", "year": "2018", "unstructured": "Rieder EA (2018) In response to Lebwohl et al, \u201cpsychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trials\u201d. J Am Acad Dermatol 78:e73. \n                    https://doi.org/10.1016/j.jaad.2017.10.052", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR116", "doi-asserted-by": "publisher", "first-page": "1653", "DOI": "10.1080/14740338.2016.1228872", "volume": "15", "author": "A Chiricozzi", "year": "2016", "unstructured": "Chiricozzi A, Romanelli M, Saraceno R, Torres T (2016) No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents. Expert Opin Drug Saf 15:1653\u20131659. \n                    https://doi.org/10.1080/14740338.2016.1228872", "journal-title": "Expert Opin Drug Saf"}, {"key": "8702_CR117", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1038/jid.2010.374", "volume": "131", "author": "RA Clark", "year": "2011", "unstructured": "Clark RA (2011) Gone but not forgotten: lesional memory in psoriatic skin. J Invest Dermatol 131:283\u2013285. \n                    https://doi.org/10.1038/jid.2010.374", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR118", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1038/jid.2010.280", "volume": "131", "author": "M Su\u00e1rez-Fari\u00f1as", "year": "2011", "unstructured": "Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Lowes MA, Krueger JG (2011) Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 131:391\u2013400. \n                    https://doi.org/10.1038/jid.2010.280", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR119", "doi-asserted-by": "publisher", "first-page": "e30308", "DOI": "10.1371/journal.pone.0030308", "volume": "7", "author": "LM Johnson-Huang", "year": "2012", "unstructured": "Johnson-Huang LM, Pensabene CA, Shah KR, Pierson KC, Kikuchi T, Lentini T, Gilleaudeau P, Sullivan-Whalen M, Cueto I, Khatcherian A, Hyder LA, Su\u00e1rez-Fari\u00f1as M, Krueger JG, Lowes MA (2012) Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs. PLoS One 7:e30308. \n                    https://doi.org/10.1371/journal.pone.0030308", "journal-title": "PLoS One"}, {"key": "8702_CR120", "doi-asserted-by": "publisher", "first-page": "4031", "DOI": "10.1172/JCI93396", "volume": "127", "author": "TR Matos", "year": "2017", "unstructured": "Matos TR, O'Malley JT, Lowry EL, Hamm D, Kirsch IR, Robins HS, Kupper TS, Krueger JG, Clark RA (2017) Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones. J Clin Invest 127:4031\u20134041. \n                    https://doi.org/10.1172/JCI93396", "journal-title": "J Clin Invest"}, {"key": "8702_CR121", "doi-asserted-by": "publisher", "first-page": "60", "DOI": "10.1016/j.jaad.2016.08.008", "volume": "76", "author": "A Blauvelt", "year": "2017", "unstructured": "Blauvelt A, Reich K, Tsai TF, Tyring S, Vanaclocha F, Kingo K, Ziv M, Pinter A, Vender R, Hugot S, You R, Milutinovic M, Tha\u00e7i D (2017) Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: results from the CLEAR study. J Am Acad Dermatol 76:60\u201369.e9. \n                    https://doi.org/10.1016/j.jaad.2016.08.008", "journal-title": "J Am Acad Dermatol"}, {"key": "8702_CR122", "doi-asserted-by": "publisher", "first-page": "923", "DOI": "10.1016/j.jaci.2016.06.038", "volume": "139", "author": "F Kolbinger", "year": "2017", "unstructured": "Kolbinger F, Loesche C, Valentin MA, Jiang X, Cheng Y, Jarvis P, Peters T, Calonder C, Bruin G, Polus F, Aigner B, Lee DM, Bodenlenz M, Sinner F, Pieber TR, Patel DD (2017) \u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis. J Allergy Clin Immunol 139:923\u2013932.e8. \n                    https://doi.org/10.1016/j.jaci.2016.06.038", "journal-title": "J Allergy Clin Immunol"}, {"key": "8702_CR123", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.18063/APM.2016.02.003", "volume": "1", "author": "C Loesche", "year": "2016", "unstructured": "Loesche C, Kolbinger F, Valentin MA, Jarvis P, Ceci M, Wieczorek G, Khokhlovich E, Koroleva I, Bruin G, Sinner F, Aigner B, Patel DD (2016) Interleukin-17A blockade with secukinumab results in decreased neutrophil infiltration in psoriasis: minimally-invasive measurement by tape stripping. Adv Precision Med 1:1\u20139", "journal-title": "Adv Precision Med"}, {"key": "8702_CR124", "doi-asserted-by": "publisher", "first-page": "ii43", "DOI": "10.1093/rheumatology/kew346", "volume": "55", "author": "A Nirula", "year": "2016", "unstructured": "Nirula A, Nilsen J, Klekotka P, Kricorian G, Erondu N, Towne JE, Russell CB, Martin DA, Budelsky AL (2016) Effect of IL-17 receptor a blockade with brodalumab in inflammatory diseases. Rheumatology (Oxford) 55:ii43\u2013ii55. \n                    https://doi.org/10.1093/rheumatology/kew346", "journal-title": "Rheumatology (Oxford)"}, {"key": "8702_CR125", "doi-asserted-by": "publisher", "first-page": "3828", "DOI": "10.4049/jimmunol.1301737", "volume": "192", "author": "CB Russell", "year": "2014", "unstructured": "Russell CB, Rand H, Bigler J, Kerkof K, Timour M, Bautista E, Krueger JG, Salinger DH, Welcher AA, Martin DA (2014) Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol 192:3828\u20133836. \n                    https://doi.org/10.4049/jimmunol.1301737", "journal-title": "J Immunol"}, {"key": "8702_CR126", "unstructured": "Maroof A, Okoye R, Smallie T, Baeten D, Archer S, Simpson C, Griffiths M, Shaw S (2017) Bimekizumab dual inhibition of IL-17A and IL-17F provides evidence of IL-17F contribution to chronic inflammation in disease-relevant cells [abstract]. Arthritis Rheumatol 69(Suppl 10):Abstract 1571", "DOI": "10.1136/annrheumdis-2017-eular.4966", "doi-asserted-by": "crossref"}, {"key": "8702_CR127", "doi-asserted-by": "publisher", "first-page": "A13", "DOI": "10.1136/annrheumdis-2016-210799", "volume": "76", "author": "A Maroof", "year": "2017", "unstructured": "Maroof A, Baeten D, Archer S, Griffiths M, Shaw S (2017) IL-17F contributes to human chronic inflammation in synovial tissue: preclinical evidence with dual IL-17a and IL-17F inhibition with bimekizumab in psoriatic arthritis. Ann Rheum Dis 76:A13", "journal-title": "Ann Rheum Dis"}, {"key": "8702_CR128", "doi-asserted-by": "publisher", "first-page": "S120", "DOI": "10.1016/j.jid.2017.02.722", "volume": "137", "author": "A Maroof", "year": "2017", "unstructured": "Maroof A, Smallie T, Archer S, Simpson C, Griffiths M, Baeten D, Shaw S (2017) Dual IL-17A and IL-17F inhibition with bimekizumab provides evidence for IL-17F contribution in immune-mediated inflammatory skin response [abstract]. J Invest Dermatol 137:S120 Abstract 699", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR129", "doi-asserted-by": "publisher", "first-page": "627", "DOI": "10.2340/00015555-1833", "volume": "94", "author": "K Vlam de", "year": "2014", "unstructured": "de Vlam K, Gottlieb AB, Mease PJ (2014) Current concepts in psoriatic arthritis: pathogenesis and management. Acta Derm Venereol 94:627\u2013634. \n                    https://doi.org/10.2340/00015555-1833", "journal-title": "Acta Derm Venereol"}, {"key": "8702_CR130", "doi-asserted-by": "publisher", "first-page": "623", "DOI": "10.1016/j.rdc.2015.07.002", "volume": "41", "author": "DD O'Rielly", "year": "2015", "unstructured": "O'Rielly DD, Rahman P (2015) Genetic, epigenetic and pharmacogenetic aspects of psoriasis and psoriatic arthritis. Rheum Dis Clin N Am 41:623\u2013642. \n                    https://doi.org/10.1016/j.rdc.2015.07.002", "journal-title": "Rheum Dis Clin N Am"}, {"key": "8702_CR131", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.5152/eurjrheum.2017.17037", "volume": "4", "author": "EA Wang", "year": "2017", "unstructured": "Wang EA, Suzuki E, Maverakis E, Adamopoulos IE (2017) Targeting IL-17 in psoriatic arthritis. Eur J Rheumatol 4:272\u2013277. \n                    https://doi.org/10.5152/eurjrheum.2017.17037", "journal-title": "Eur J Rheumatol"}, {"key": "8702_CR132", "doi-asserted-by": "publisher", "first-page": "1329", "DOI": "10.1056/NEJMoa1412679", "volume": "373", "author": "PJ Mease", "year": "2015", "unstructured": "Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landew\u00e9 R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S, FUTURE 1 Study Group (2015) Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N Engl J Med 373:1329\u20131339. \n                    https://doi.org/10.1056/NEJMoa1412679", "journal-title": "N Engl J Med"}, {"key": "8702_CR133", "doi-asserted-by": "publisher", "first-page": "1137", "DOI": "10.1016/S0140-6736(15)61134-5", "volume": "386", "author": "IB McInnes", "year": "2015", "unstructured": "McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landew\u00e9 R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S, FUTURE 2 Study Group (2015) Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386:1137\u20131146. \n                    https://doi.org/10.1016/S0140-6736(15)61134-5", "journal-title": "Lancet"}, {"key": "8702_CR134", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1136/annrheumdis-2016-209709", "volume": "76", "author": "PJ Mease", "year": "2017", "unstructured": "Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD, SPIRIT-P1 Study Group (2017) Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann Rheum Dis 76:79\u201387. \n                    https://doi.org/10.1136/annrheumdis-2016-209709", "journal-title": "Ann Rheum Dis"}, {"key": "8702_CR135", "doi-asserted-by": "publisher", "first-page": "2317", "DOI": "10.1016/S0140-6736(17)31429-0", "volume": "389", "author": "P Nash", "year": "2017", "unstructured": "Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M, SPIRIT-P2 Study Group (2017) Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. Lancet 389:2317\u20132327. \n                    https://doi.org/10.1016/S0140-6736(17)31429-0", "journal-title": "Lancet"}, {"key": "8702_CR136", "doi-asserted-by": "publisher", "first-page": "2295", "DOI": "10.1056/NEJMoa1315231", "volume": "370", "author": "PJ Mease", "year": "2014", "unstructured": "Mease PJ, Genovese MC, Greenwald MW, Ritchlin CT, Beaulieu AD, Deodhar A, Newmark R, Feng J, Erondu N, Nirula A (2014) Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis. N Engl J Med 370:2295\u20132306. \n                    https://doi.org/10.1056/NEJMoa1315231", "journal-title": "N Engl J Med"}, {"issue": "Suppl 1", "key": "8702_CR137", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1016/S0001-7310(14)70015-8", "volume": "105", "author": "A Mitra", "year": "2014", "unstructured": "Mitra A, Raychaudhuri SK, Raychaudhuri SP (2014) IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease. Actas Dermosifiliogr 105(Suppl 1):21\u201333. \n                    https://doi.org/10.1016/S0001-7310(14)70015-8", "journal-title": "Actas Dermosifiliogr"}, {"key": "8702_CR138", "doi-asserted-by": "publisher", "first-page": "699", "DOI": "10.1097/01.mca.0000236288.94553.b4", "volume": "17", "author": "S Hashmi", "year": "2006", "unstructured": "Hashmi S, Zeng QT (2006) Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 17:699\u2013706. \n                    https://doi.org/10.1097/01.mca.0000236288.94553.b4", "journal-title": "Coron Artery Dis"}, {"key": "8702_CR139", "doi-asserted-by": "publisher", "first-page": "2658", "DOI": "10.1161/ATVBAHA.114.304108", "volume": "34", "author": "S Karbach", "year": "2014", "unstructured": "Karbach S, Croxford AL, Oelze M, Schuler R, Minwegen D, Wegner J, Koukes L, Yogev N, Nikolaev A, Rei\u00dfig S, Ullmann A, Knorr M, Waldner M, Neurath MF, Li H, Wu Z, Brochhausen C, Scheller J, Rose-John S, Piotrowski C, Bechmann I, Radsak M, Wild P, Daiber A, von Stebut E, Wenzel P, Waisman A, M\u00fcnzel T (2014) Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol 34:2658\u20132668. \n                    https://doi.org/10.1161/ATVBAHA.114.304108", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "8702_CR140", "doi-asserted-by": "publisher", "first-page": "310", "DOI": "10.1016/j.jid.2017.09.021", "volume": "138", "author": "Y Li", "year": "2018", "unstructured": "Li Y, Golden JB, Camhi MI, Zhang X, Fritz Y, Diaconu D, Ivanco TL, Simon DI, Kikly K, McCormick TS, Wang Y, Ward NL (2018) Protection from psoriasis-related thrombosis after inhibition of IL-23 or IL-17A. J Invest Dermatol 138:310\u2013315. \n                    https://doi.org/10.1016/j.jid.2017.09.021", "journal-title": "J Invest Dermatol"}, {"key": "8702_CR141", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1093/eurheartj/ehs263", "volume": "34", "author": "T Simon", "year": "2013", "unstructured": "Simon T, Taleb S, Danchin N, Laurans L, Rousseau B, Cattan S, Montely JM, Dubourg O, Tedgui A, Kotti S, Mallat Z (2013) Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur Heart J 34:570\u2013577. \n                    https://doi.org/10.1093/eurheartj/ehs263", "journal-title": "Eur Heart J"}], "container-title": ["Clinical Reviews in Allergy & Immunology"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s12016-018-8702-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12016-018-8702-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12016-018-8702-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 13]], "date-time": "2019-08-13T23:17:47Z", "timestamp": 1565738267000}, "score": 33.40748, "issued": {"date-parts": [[2018, 8, 14]]}, "references-count": 141, "journal-issue": {"published-print": {"date-parts": [[2018, 12]]}, "issue": "3"}, "alternative-id": ["8702"], "URL": "http://dx.doi.org/10.1007/s12016-018-8702-3", "relation": {"cites": []}, "ISSN": ["1080-0549", "1559-0267"], "issn-type": [{"value": "1080-0549", "type": "print"}, {"value": "1559-0267", "type": "electronic"}], "assertion": [{"value": "14 August 2018", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with Ethical Standards"}}, {"value": "A Blauvelt has been a scientific adviser and clinical study investigator for AbbVie, Aclaris, Akros, Allergan, Almirall, Amgen, Boehringer-Ingelheim, Celgene, Dermavant, Dermira, Inc., Eli Lilly and Company, Galderma, Genentech/Roche, GlaxoSmithKline, Janssen, Leo Pharma, Meiji, Merck Sharp & Dohme, Novartis, Pfizer, Purdue Pharma, Regeneron, Revance, Sandoz, Sanofi Genzyme, Sienna Pharmaceuticals, Sun Pharma, UCB Pharma, Valeant, and Vidac, and a paid speaker for Janssen, Regeneron, and Sanofi Genzyme. A Chiricozzi has been a scientific consultant and/or clinical study investigator for AbbVie, Biogen, Eli Lilly and Company, Janssen, Leo Pharma, Novartis, Sanofi Genzyme, and a speaker for Eli Lilly and Company, Janssen, AbbVie, and Novartis.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of Interest"}}, {"value": "This article does not contain any studies with human participants or animals performed by either author.", "order": 3, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Ethical Approval"}}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:11:03Z", "timestamp": 1575231063275}, "reference-count": 99, "publisher": "Informa Healthcare", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Opinion on Investigational Drugs"], "published-print": {"date-parts": [[2013, 8]]}, "DOI": "10.1517/13543784.2013.806483", "type": "journal-article", "created": {"date-parts": [[2013, 6, 4]], "date-time": "2013-06-04T07:02:10Z", "timestamp": 1370329330000}, "page": "993-1005", "source": "Crossref", "is-referenced-by-count": 83, "title": ["IL-17 targeted therapies for psoriasis"], "prefix": "10.1517", "volume": "22", "author": [{"given": "Andrea", "family": "Chiricozzi", "sequence": "first", "affiliation": [{"name": "The Rockefeller University, Laboratory for Investigative Dermatology,\r1230 York Avenue, 10065 New York City, NY, USA ; ;"}, {"name": "Visiting Dermatologist at the Laboratory for Investigative Dermatology, University of Rome Tor Vergata, Department of Dermatology,\rVia Montpellier 1, 00133, Rome, Italy"}]}, {"given": "James G", "family": "Krueger", "sequence": "additional", "affiliation": [{"name": "The Rockefeller University, Laboratory for Investigative Dermatology,\r1230 York Avenue, 10065 New York City, NY, USA ; ;"}, {"name": "The Rockefeller University,\r1230 York Avenue, 10065 New York City, NY, USA"}]}], "member": "3197", "published-online": {"date-parts": [[2013, 6, 3]]}, "reference": [{"key": "CIT0001", "DOI": "10.1159/000092283", "doi-asserted-by": "publisher"}, {"issue": "11", "key": "CIT0002", "first-page": "946", "volume": "7", "author": "Boehncke WH", "year": "2009", "journal-title": "J Dtsch Dermatol Ges"}, {"key": "CIT0003", "DOI": "10.1038/jid.2010.103", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1111/j.1396-0296.2004.04038.x", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1001/archderm.141.12.1527", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1007/s00403-006-0703-z", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1111/j.1365-2133.2007.08190.x", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1016/0190-9622(95)91336-X", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "CIT0009", "first-page": "199", "volume": "40", "author": "Ena P", "year": "1985", "journal-title": "Acta Cardiol"}, {"key": "CIT0010", "DOI": "10.1111/j.1365-2133.1978.tb02012.x", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1001/jama.296.14.1735", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1111/j.1365-2133.2011.10774.x", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.2340/00015555-0741", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1159/000090652", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1016/S0190-9622(99)70112-X", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1111/j.1365-2133.2010.10006.x", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1046/j.1365-2133.2002.04899.x", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1111/j.1468-3083.2009.03389.x", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "author": "Menter A", "volume": "84", "first-page": "14", "year": "2009", "journal-title": "Cutis"}, {"key": "CIT0020", "DOI": "10.1056/NEJMoa062382", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1038/sj.jid.5701213", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.1056/NEJMra0707449", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1016/S0083-6729(06)74010-9", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "author": "Rouvier E", "volume": "150", "first-page": "5445", "year": "1993", "journal-title": "J Immunol"}, {"issue": "12", "key": "CIT0025", "first-page": "5483", "volume": "155", "author": "Yao Z", "year": "1995", "journal-title": "J Immunol"}, {"key": "CIT0026", "DOI": "10.1038/ni1254", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1189/JLB.0109046", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.4049/jimmunol.1100804", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.4049/jimmunol.1100123", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1016/j.coi.2011.07.006", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "DOI": "10.1038/nri2586", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1093/emboj/20.19.5332", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1016/S1359-6101(03)00002-9", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.4049/jimmunol.169.1.443", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1182/blood-2002-01-0012", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1128/IAI.73.1.617-621.2005", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1084/jem.194.4.519", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1086/422329", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.4049/jimmunol.170.9.4432", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1172/JCI21404", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.3109/08916934.2010.517815", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.4049/jimmunol.177.1.566", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1038/nature01355", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1084/jem.20041257", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1038/nature05663", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.1016/j.jaci.2012.04.024", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1186/ar2297", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.1371/journal.pgen.1000041", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "DOI": "10.1038/jid.2012.456", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1067/mjd.2002.120568", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "DOI": "10.1016/j.clindermatol.2007.08.013", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "DOI": "10.1016/j.clindermatol.2007.08.011", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "DOI": "10.1073/pnas.0509736102", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "DOI": "10.1038/jid.2008.225", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "DOI": "10.1172/JCI117308", "doi-asserted-by": "publisher"}, {"key": "CIT0056", "DOI": "10.1056/NEJMra0804595", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "DOI": "10.1074/jbc.M207577200", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1016/S1074-7613(00)00070-4", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1038/jid.2010.340", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "author": "Nograles KE", "volume": "159", "first-page": "1086", "year": "2008", "journal-title": "Br J Dermatol"}, {"key": "CIT0061", "DOI": "10.1084/jem.180.3.1141", "doi-asserted-by": "publisher"}, {"key": "CIT0062", "DOI": "10.1084/jem.177.4.1199", "doi-asserted-by": "publisher"}, {"key": "CIT0063", "DOI": "10.1038/ni.1610", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1038/nature07036", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1038/nature07021", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1038/ni.1767", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "DOI": "10.1038/ni.1770", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "DOI": "10.4049/jimmunol.0900036", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "DOI": "10.1002/eji.200939412", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "DOI": "10.1016/j.immuni.2011.08.001", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "DOI": "10.1038/jid.2008.194", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "DOI": "10.1371/journal.pone.0014108", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "DOI": "10.1038/ng.311", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "DOI": "10.1038/sj.jid.5701255", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "DOI": "10.1086/428480", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1038/ng.694", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "DOI": "10.1038/ng.688", "doi-asserted-by": "publisher"}, {"key": "CIT0078", "DOI": "10.1038/ng.2007.48", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.1038/jid.2012.194", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "DOI": "10.1084/jem.20060244", "doi-asserted-by": "publisher"}, {"key": "CIT0081", "DOI": "10.4049/jimmunol.1001001", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.4049/jimmunol.176.3.1908", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1084/jem.20030451", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "DOI": "10.1016/j.jaci.2009.08.046", "doi-asserted-by": "publisher"}, {"key": "CIT0085", "DOI": "10.1038/jid.2010.166", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.1084/jem.20071094", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "DOI": "10.4049/jimmunol.180.3.1913", "doi-asserted-by": "publisher"}, {"key": "CIT0088", "DOI": "10.4049/jimmunol.164.12.6621", "doi-asserted-by": "publisher"}, {"key": "CIT0089", "DOI": "10.1056/NEJMoa1109997", "doi-asserted-by": "publisher"}, {"key": "CIT0091", "author": "Russell CB", "volume": "130", "first-page": "S46", "year": "2010", "journal-title": "J Invest Dermatol"}, {"key": "CIT0092", "DOI": "10.1056/NEJMoa1109017", "doi-asserted-by": "publisher"}, {"key": "CIT0094", "DOI": "10.1126/scitranslmed.3001107", "doi-asserted-by": "publisher"}, {"key": "CIT0095", "DOI": "10.1111/bjd.12110", "doi-asserted-by": "publisher"}, {"key": "CIT0096", "author": "Rich P", "year": "2012", "journal-title": "Br J Dermatol"}, {"key": "CIT0097", "author": "McInnes IB", "year": "2013", "journal-title": "Ann Rheum Dis"}, {"key": "CIT0099", "DOI": "10.1111/bjd.12214", "doi-asserted-by": "publisher"}, {"key": "CIT0100", "DOI": "10.1038/nm.3025", "doi-asserted-by": "publisher"}, {"key": "CIT0101", "DOI": "10.1159/000314626", "doi-asserted-by": "publisher"}, {"key": "CIT0102", "DOI": "10.1001/archderm.143.12.1493", "doi-asserted-by": "publisher"}], "container-title": ["Expert Opinion on Investigational Drugs"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1517/13543784.2013.806483", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:35:53Z", "timestamp": 1536251753000}, "score": 32.184383, "issued": {"date-parts": [[2013, 6, 3]]}, "references-count": 99, "journal-issue": {"published-online": {"date-parts": [[2013, 7]]}, "published-print": {"date-parts": [[2013, 8]]}, "issue": "8"}, "alternative-id": ["10.1517/13543784.2013.806483"], "URL": "http://dx.doi.org/10.1517/13543784.2013.806483", "relation": {"cites": []}, "ISSN": ["1354-3784", "1744-7658"], "issn-type": [{"value": "1354-3784", "type": "print"}, {"value": "1744-7658", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T04:42:32Z", "timestamp": 1574829752819}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 9, 1]], "date-time": "2016-09-01T00:00:00Z", "timestamp": 1472688000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2017, 9, 1]], "date-time": "2017-09-01T00:00:00Z", "timestamp": 1504224000000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Investigative Dermatology"], "published-print": {"date-parts": [[2016, 9]]}, "DOI": "10.1016/j.jid.2016.06.154", "type": "journal-article", "created": {"date-parts": [[2016, 8, 16]], "date-time": "2016-08-16T08:30:59Z", "timestamp": 1471336259000}, "page": "S183", "source": "Crossref", "is-referenced-by-count": 0, "title": ["136 MiR-10a controls the proliferation and inflammatory responses of human primary keratinocytes. MiR-10a controls the proliferation and inflammatory responses of human primary keratinocytes"], "prefix": "10.1016", "volume": "136", "author": [{"given": "T.", "family": "Runnel", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Hermann", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Urgard", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Kingo", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "\u0160ahmatova", "sequence": "additional", "affiliation": []}, {"given": "C.A.", "family": "Akdis", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Maimets", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Rebane", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Investigative Dermatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022202X16315068?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022202X16315068?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 9]], "date-time": "2018-09-09T05:59:18Z", "timestamp": 1536472758000}, "score": 28.886843, "issued": {"date-parts": [[2016, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 9]]}, "issue": "9"}, "alternative-id": ["S0022202X16315068"], "URL": "http://dx.doi.org/10.1016/j.jid.2016.06.154", "ISSN": ["0022-202X"], "issn-type": [{"value": "0022-202X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T23:45:16Z", "timestamp": 1575503116783}, "reference-count": 110, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/3.0/", "start": {"date-parts": [[2014, 1, 1]], "date-time": "2014-01-01T00:00:00Z", "timestamp": 1388534400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Immunology Research"], "published-print": {"date-parts": [[2014]]}, "abstract": "<jats:p>Psoriasis vulgaris (PV) is a cutaneous inflammatory disorder stemming from abnormal, persistent activation of the interleukin- (IL-)23/Th17 axis. Pustular psoriasis (PP) is a clinicopathological variant of psoriasis, histopathologically defined by the predominance of intraepidermal collections of neutrophils. Although PP pathogenesis is thought to largely follow that of (PV), recent evidences point to a more central role for IL-1, IL-36, and IL-6 in the development of PP. We review the role of IL-6 in the pathogenesis of PV and PP, focusing on its cross-talk with cytokines of the IL-23/Th17 axis. Clinical inhibitors of IL-6 signaling, including tocilizumab, have shown significant effectiveness in the treatment of several inflammatory rheumatic diseases, including rheumatoid arthritis and juvenile idiopathic arthritis; accordingly, anti-IL-6 agents may potentially represent future promising therapies for the treatment of PP.</jats:p>", "DOI": "10.1155/2014/964069", "type": "journal-article", "created": {"date-parts": [[2014, 7, 13]], "date-time": "2014-07-13T21:08:01Z", "timestamp": 1405285681000}, "page": "1-10", "source": "Crossref", "is-referenced-by-count": 23, "title": ["IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants"], "prefix": "10.1155", "volume": "2014", "author": [{"ORCID": "http://orcid.org/0000-0001-8814-441X", "authenticated-orcid": true, "given": "Andrea", "family": "Saggini", "sequence": "first", "affiliation": [{"name": "Department of Dermatology, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy"}]}, {"ORCID": "http://orcid.org/0000-0003-3750-1792", "authenticated-orcid": true, "given": "Sergio", "family": "Chimenti", "sequence": "additional", "affiliation": [{"name": "Department of Dermatology, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy"}]}, {"ORCID": "http://orcid.org/0000-0002-6739-0387", "authenticated-orcid": true, "given": "Andrea", "family": "Chiricozzi", "sequence": "additional", "affiliation": [{"name": "Department of Dermatology, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy"}, {"name": "Laboratory for Investigative Dermatology, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA"}]}], "member": "98", "reference": [{"key": "1", "DOI": "10.1038/sj.jid.5701213", "doi-asserted-by": "publisher"}, {"key": "2", "DOI": "10.1038/jid.2012.194", "doi-asserted-by": "publisher"}, {"key": "3", "DOI": "10.1097/00000372-197900130-00002", "doi-asserted-by": "publisher"}, {"key": "4", "DOI": "10.1111/jdv.12240", "doi-asserted-by": "publisher"}, {"key": "5", "DOI": "10.1038/jid.2009.59", "doi-asserted-by": "publisher"}, {"key": "6", "DOI": "10.1038/jid.2011.222", "doi-asserted-by": "publisher"}, {"key": "7", "DOI": "10.1038/jid.2009.399", "doi-asserted-by": "publisher"}, {"key": "8", "volume": "12", "first-page": "S1", "year": "2008", "journal-title": "Journal of Cutaneous Medicine and Surgery", "DOI": "10.2310/7750.2008/08070", "doi-asserted-by": "crossref"}, {"key": "9", "DOI": "10.1111/j.1600-0560.2010.01612.x", "doi-asserted-by": "publisher"}, {"key": "10", "volume": "59", "issue": "85", "first-page": "147", "year": "1979", "journal-title": "Acta Dermato-Venereologica"}, {"key": "11", "DOI": "10.4049/jimmunol.181.1.669", "doi-asserted-by": "publisher"}, {"key": "12", "volume": "1", "issue": "1", "first-page": "69", "year": "1979", "journal-title": "The American Journal of Dermatopathology"}, {"key": "13", "volume": "19", "issue": "3", "first-page": "209", "year": "2011", "journal-title": "Acta Dermatovenerologica Croatica"}, {"key": "14", "DOI": "10.1016/j.jaad.2011.01.032", "doi-asserted-by": "publisher"}, {"key": "15", "DOI": "10.2165/11586900-000000000-00000", "doi-asserted-by": "publisher"}, {"key": "16", "DOI": "10.1016/j.jaad.2012.09.037", "doi-asserted-by": "publisher"}, {"key": "17", "DOI": "10.1016/j.det.2013.04.001", "doi-asserted-by": "publisher"}, {"key": "18", "DOI": "10.1111/bjd.12223", "doi-asserted-by": "publisher"}, {"key": "19", "DOI": "10.1001/2013.jamadermatol.80", "doi-asserted-by": "publisher"}, {"key": "20", "DOI": "10.1016/j.jaad.2012.11.017", "doi-asserted-by": "publisher"}, {"key": "21", "volume": "7", "issue": "10", "first-page": "975", "year": "2008", "journal-title": "Journal of Drugs in Dermatology"}, {"key": "22", "DOI": "10.3109/09546630902882089", "doi-asserted-by": "publisher"}, {"key": "23", "DOI": "10.1038/jid.2013.404", "doi-asserted-by": "publisher"}, {"key": "24", "DOI": "10.1111/bjd.12548", "doi-asserted-by": "publisher"}, {"key": "25", "DOI": "10.1038/jid.2013.361", "doi-asserted-by": "publisher"}, {"key": "26", "DOI": "10.1016/j.cytogfr.2010.10.006", "doi-asserted-by": "publisher"}, {"key": "27", "DOI": "10.1084/jem.20030451", "doi-asserted-by": "publisher"}, {"key": "28", "DOI": "10.1074/jbc.M207577200", "doi-asserted-by": "publisher"}, {"key": "29", "DOI": "10.1093/intimm/dxr001", "doi-asserted-by": "publisher"}, {"key": "30", "DOI": "10.4049/jimmunol.1001001", "doi-asserted-by": "publisher"}, {"key": "31", "DOI": "10.4049/jimmunol.1003326", "doi-asserted-by": "publisher"}, {"key": "32", "DOI": "10.2741/4054", "doi-asserted-by": "publisher"}, {"key": "33", "DOI": "10.1038/jid.2013.324", "doi-asserted-by": "publisher"}, {"key": "34", "DOI": "10.1111/j.1365-2133.2008.08769.x", "doi-asserted-by": "publisher"}, {"key": "35", "DOI": "10.1038/jid.2010.340", "doi-asserted-by": "publisher"}, {"key": "36", "DOI": "10.1016/j.it.2012.11.005", "doi-asserted-by": "publisher"}, {"key": "37", "DOI": "10.1517/13543784.2013.806483", "doi-asserted-by": "publisher"}, {"key": "38", "volume": "38", "issue": "5", "first-page": "288", "year": "2013", "journal-title": "P & T"}, {"key": "39", "DOI": "10.1155/MI.2005.273", "doi-asserted-by": "publisher"}, {"key": "40", "DOI": "10.4049/jimmunol.1102224", "doi-asserted-by": "publisher"}, {"key": "41", "DOI": "10.1038/jid.2012.318", "doi-asserted-by": "publisher"}, {"key": "42", "DOI": "10.4049/jimmunol.1101817", "doi-asserted-by": "publisher"}, {"key": "43", "DOI": "10.4049/jimmunol.0802999", "doi-asserted-by": "publisher"}, {"key": "44", "DOI": "10.1111/jdv.12272", "doi-asserted-by": "publisher"}, {"key": "45", "DOI": "10.1684/ejd.2010.1164", "doi-asserted-by": "publisher"}, {"key": "46", "DOI": "10.3109/09546634.2010.534430", "doi-asserted-by": "publisher"}, {"key": "47", "DOI": "10.1097/ACI.0b013e328358cc0b", "doi-asserted-by": "publisher"}, {"key": "48", "volume": "43", "issue": "10", "first-page": "2671", "year": "2013", "journal-title": "European Journal of Immunology", "DOI": "10.1002/eji.201242891", "doi-asserted-by": "crossref"}, {"key": "49", "DOI": "10.1002/eji.201242605", "doi-asserted-by": "publisher"}, {"key": "50", "DOI": "10.4049/jimmunol.1202924", "doi-asserted-by": "publisher"}, {"key": "51", "DOI": "10.1016/j.chom.2012.04.008", "doi-asserted-by": "publisher"}, {"key": "52", "DOI": "10.4049/jimmunol.1100123", "doi-asserted-by": "publisher"}, {"key": "53", "DOI": "10.1038/jid.2013.267", "doi-asserted-by": "publisher"}, {"key": "54", "DOI": "10.1056/NEJMoa1013068", "doi-asserted-by": "publisher"}, {"key": "55", "DOI": "10.1016/j.coph.2012.02.009", "doi-asserted-by": "publisher"}, {"key": "56", "volume": "26", "issue": "1", "first-page": "7", "year": "2012", "journal-title": "Journal of Biological Regulators and Homeostatic Agents"}, {"key": "57", "DOI": "10.1038/jid.2013.214", "doi-asserted-by": "publisher"}, {"key": "58", "DOI": "10.1111/j.1365-2133.2011.10302.x", "doi-asserted-by": "publisher"}, {"key": "59", "DOI": "10.4049/jimmunol.1000313", "doi-asserted-by": "publisher"}, {"key": "60", "DOI": "10.1038/jid.2011.234", "doi-asserted-by": "publisher"}, {"key": "61", "DOI": "10.1172/JCI63451", "doi-asserted-by": "publisher"}, {"key": "62", "DOI": "10.1038/jid.2012.512", "doi-asserted-by": "publisher"}, {"key": "63", "DOI": "10.4049/jimmunol.1003162", "doi-asserted-by": "publisher"}, {"key": "64", "DOI": "10.1542/peds.2012-3935", "doi-asserted-by": "publisher"}, {"key": "65", "DOI": "10.1038/jid.2012.490", "doi-asserted-by": "publisher"}, {"key": "66", "DOI": "10.1038/jid.2013.230", "doi-asserted-by": "publisher"}, {"key": "67", "DOI": "10.1038/jid.2013.285", "doi-asserted-by": "publisher"}, {"key": "68", "DOI": "10.1016/j.cytogfr.2011.02.003", "doi-asserted-by": "publisher"}, {"key": "69", "DOI": "10.1016/j.it.2012.07.003", "doi-asserted-by": "publisher"}, {"key": "70", "DOI": "10.1172/JCI57158", "doi-asserted-by": "publisher"}, {"key": "71", "DOI": "10.1038/jid.2010.255", "doi-asserted-by": "publisher"}, {"key": "72", "DOI": "10.1016/j.cytogfr.2012.09.001", "doi-asserted-by": "publisher"}, {"key": "73", "DOI": "10.7150/ijbs.4989", "doi-asserted-by": "publisher"}, {"key": "74", "DOI": "10.4049/jimmunol.0803721", "doi-asserted-by": "publisher"}, {"key": "75", "DOI": "10.1016/S1359-6101(02)00027-8", "doi-asserted-by": "publisher"}, {"key": "76", "DOI": "10.1016/j.immuni.2008.07.018", "doi-asserted-by": "publisher"}, {"key": "77", "DOI": "10.1016/S1074-7613(00)80334-9", "doi-asserted-by": "publisher"}, {"key": "78", "DOI": "10.1172/JCI200317129", "doi-asserted-by": "publisher"}, {"key": "79", "volume": "24", "issue": "6", "first-page": "299", "year": "2003", "journal-title": "Trends in immunology", "DOI": "10.1016/S1471-4906(03)00113-3", "doi-asserted-by": "crossref"}, {"key": "80", "DOI": "10.1016/S1471-4906(02)00013-3", "doi-asserted-by": "publisher"}, {"key": "81", "DOI": "10.1097/BOR.0b013e3283456797", "doi-asserted-by": "publisher"}, {"key": "82", "DOI": "10.1517/14712598.2013.735657", "doi-asserted-by": "publisher"}, {"key": "83", "volume": "72", "issue": "3", "first-page": "165", "year": "1992", "journal-title": "Acta Dermato-Venereologica"}, {"key": "84", "DOI": "10.1111/1523-1747.ep12477880", "doi-asserted-by": "publisher"}, {"key": "85", "DOI": "10.1073/pnas.86.16.6367", "doi-asserted-by": "publisher"}, {"key": "86", "DOI": "10.2340/00015555-0427", "doi-asserted-by": "publisher"}, {"key": "87", "DOI": "10.1016/j.imlet.2013.09.028", "doi-asserted-by": "publisher"}, {"key": "88", "DOI": "10.1038/jid.2011.376", "doi-asserted-by": "publisher"}, {"key": "89", "DOI": "10.1097/FPC.0b013e32834e5e7b", "doi-asserted-by": "publisher"}, {"key": "90", "volume": "762", "first-page": "432", "year": "1995", "journal-title": "Annals of the New York Academy of Sciences"}, {"key": "91", "DOI": "10.1016/S0923-1811(96)00562-2", "doi-asserted-by": "publisher"}, {"key": "92", "DOI": "10.1016/j.jdermsci.2010.03.018", "doi-asserted-by": "publisher"}, {"key": "93", "DOI": "10.1111/j.1365-2249.2012.04618.x", "doi-asserted-by": "publisher"}, {"key": "94", "DOI": "10.1007/s00403-010-1033-8", "doi-asserted-by": "publisher"}, {"key": "95", "DOI": "10.1016/j.jaci.2010.12.009", "doi-asserted-by": "publisher"}, {"key": "96", "DOI": "10.1038/jid.2010.432", "doi-asserted-by": "publisher"}, {"key": "97", "DOI": "10.4049/jimmunol.1000148", "doi-asserted-by": "publisher"}, {"key": "98", "DOI": "10.1038/nm1162", "doi-asserted-by": "publisher"}, {"key": "99", "DOI": "10.1038/jid.2013.182", "doi-asserted-by": "publisher"}, {"key": "100", "DOI": "10.1159/000063919", "doi-asserted-by": "publisher"}, {"key": "101", "DOI": "10.3233/DMA-120958", "doi-asserted-by": "publisher"}, {"key": "102", "volume": "20", "issue": "12", "first-page": "763", "year": "1993", "journal-title": "Journal of Dermatology", "DOI": "10.1111/j.1346-8138.1993.tb01380.x", "doi-asserted-by": "crossref"}, {"key": "103", "volume": "523", "first-page": "201", "year": "1996", "journal-title": "Acta Oto-Laryngologica, Supplement"}, {"key": "104", "DOI": "10.1056/NEJMoa1109017", "doi-asserted-by": "publisher"}, {"key": "105", "DOI": "10.1016/j.jbspin.2013.03.014", "doi-asserted-by": "publisher"}, {"key": "106", "DOI": "10.3899/jrheum.111166", "doi-asserted-by": "publisher"}, {"key": "107", "DOI": "10.1111/j.1365-2133.2012.11168.x", "doi-asserted-by": "publisher"}, {"key": "108", "DOI": "10.1111/exd.12265", "doi-asserted-by": "publisher"}, {"key": "109", "DOI": "10.3899/jrheum.120304", "doi-asserted-by": "publisher"}, {"key": "110", "DOI": "10.1016/j.jbspin.2012.06.010", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Immunology Research"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/jir/2014/964069.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/jir/2014/964069.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/jir/2014/964069.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T16:38:47Z", "timestamp": 1498149527000}, "score": 27.008785, "issued": {"date-parts": [[2014]]}, "references-count": 110, "alternative-id": ["964069", "964069"], "URL": "http://dx.doi.org/10.1155/2014/964069", "relation": {"cites": []}, "ISSN": ["2314-8861", "2314-7156"], "issn-type": [{"value": "2314-8861", "type": "print"}, {"value": "2314-7156", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T12:12:32Z", "timestamp": 1574770352020}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 5, 1]], "date-time": "2017-05-01T00:00:00Z", "timestamp": 1493596800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2018, 5, 1]], "date-time": "2018-05-01T00:00:00Z", "timestamp": 1525132800000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": ["jidonline.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Investigative Dermatology"], "published-print": {"date-parts": [[2017, 5]]}, "DOI": "10.1016/j.jid.2017.02.737", "type": "journal-article", "created": {"date-parts": [[2017, 4, 12]], "date-time": "2017-04-12T11:18:31Z", "timestamp": 1491995911000}, "page": "S123", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["714 Rhodomyrtone suppresses TNF-\u03b1 and IL-17A-induced keratinocyte inflammatory responses: A potential therapeutic for psoriasis"], "prefix": "10.1016", "volume": "137", "author": [{"given": "J.", "family": "Chorachoo", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Lambert", "sequence": "additional", "affiliation": []}, {"given": "L.W.", "family": "Roberts", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Voravuthikunchai", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Johnston", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Investigative Dermatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022202X17309193?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022202X17309193?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 2]], "date-time": "2018-09-02T19:56:50Z", "timestamp": 1535918210000}, "score": 26.901028, "issued": {"date-parts": [[2017, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 5]]}, "issue": "5"}, "alternative-id": ["S0022202X17309193"], "URL": "http://dx.doi.org/10.1016/j.jid.2017.02.737", "ISSN": ["0022-202X"], "issn-type": [{"value": "0022-202X", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "714 Rhodomyrtone suppresses TNF-\u03b1 and IL-17A-induced keratinocyte inflammatory responses: A potential therapeutic for psoriasis", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Investigative Dermatology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jid.2017.02.737", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2017 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:21:23Z", "timestamp": 1574893283568}, "reference-count": 0, "publisher": "Open Access Text Pvt, Ltd.", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Transl Sci"], "DOI": "10.15761/jts.1000272", "type": "journal-article", "created": {"date-parts": [[2018, 10, 29]], "date-time": "2018-10-29T12:48:30Z", "timestamp": 1540817310000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Bimekizumab: the first bispecific biologic agent facing phase III trial program in both plaque psoriasis and psoriatic arthritis"], "prefix": "10.15761", "volume": "5", "author": [{"given": "Chiricozzi", "family": "A", "sequence": "first", "affiliation": []}, {"given": "Romanelli", "family": "M", "sequence": "additional", "affiliation": []}], "member": "6817", "published-online": {"date-parts": [[2018]]}, "container-title": ["Journal of Translational Science"], "deposited": {"date-parts": [[2018, 10, 29]], "date-time": "2018-10-29T12:48:34Z", "timestamp": 1540817314000}, "score": 26.559238, "issued": {"date-parts": [[2018]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.15761/jts.1000272", "ISSN": ["2059-268X"], "issn-type": [{"value": "2059-268X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:15:17Z", "timestamp": 1574122517259}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "17", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2001, 8, 1]]}, "DOI": "10.1093/hmg/10.17.1793", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T22:48:15Z", "timestamp": 1027723695000}, "page": "1793-1805", "source": "Crossref", "is-referenced-by-count": 167, "title": ["Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies"], "prefix": "10.1093", "volume": "10", "author": [{"given": "A. M.", "family": "Bowcock", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Human Molecular Genetics"], "link": [{"URL": "http://academic.oup.com/hmg/article-pdf/10/17/1793/9813517/101793.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T08:57:56Z", "timestamp": 1503478676000}, "score": 26.282797, "issued": {"date-parts": [[2001, 8, 1]]}, "references-count": 0, "journal-issue": {"issue": "17"}, "URL": "http://dx.doi.org/10.1093/hmg/10.17.1793", "ISSN": ["1460-2083"], "issn-type": [{"value": "1460-2083", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T09:19:06Z", "timestamp": 1575364746220}, "reference-count": 11, "publisher": "Informa UK Limited", "issue": "sup2", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Dermatological Treatment"], "published-print": {"date-parts": [[2018, 12, 7]]}, "DOI": "10.1080/09546634.2018.1557875", "type": "journal-article", "created": {"date-parts": [[2018, 12, 8]], "date-time": "2018-12-08T12:55:09Z", "timestamp": 1544273709000}, "page": "1-2", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Secukinumab in the therapy of psoriasis and psoriatic arthritis: a safe choice in clinical practice"], "prefix": "10.1080", "volume": "29", "author": [{"given": "Andrea", "family": "Chiricozzi", "sequence": "first", "affiliation": [{"name": "Dermatology Unit, Department of Clinical and Translational Medicine, University of Pisa, Pisa, Italy."}]}], "member": "301", "published-online": {"date-parts": [[2018, 12, 8]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/S0001-7310(14)70014-6", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "author": "Lee E.", "volume": "14", "first-page": "1133", "year": "2015", "journal-title": "J Drugs Dermatol"}, {"key": "CIT0003", "DOI": "10.4049/jimmunol.1100123", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1016/j.jaad.2013.12.036", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.3389/fimmu.2018.01323", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1111/bjd.15029", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1016/j.jaad.2016.03.024", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1111/jdv.14878", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1080/14712598.2018.1481503", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1056/NEJMoa1412679", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1002/acr.23111", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Dermatological Treatment"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1080/09546634.2018.1557875", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 12, 26]], "date-time": "2018-12-26T07:07:53Z", "timestamp": 1545808073000}, "score": 25.612146, "issued": {"date-parts": [[2018, 12, 7]]}, "references-count": 11, "journal-issue": {"published-online": {"date-parts": [[2018, 11, 7]]}, "published-print": {"date-parts": [[2018, 12, 7]]}, "issue": "sup2"}, "alternative-id": ["10.1080/09546634.2018.1557875"], "URL": "http://dx.doi.org/10.1080/09546634.2018.1557875", "relation": {"cites": []}, "ISSN": ["0954-6634", "1471-1753"], "issn-type": [{"value": "0954-6634", "type": "print"}, {"value": "1471-1753", "type": "electronic"}], "subject": ["Dermatology"], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ijdt20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ijdt20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}, {"value": "2018-12-08", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T14:32:29Z", "timestamp": 1574346749796}, "reference-count": 55, "publisher": "American Physiological Society", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Applied Physiology"], "published-print": {"date-parts": [[2008, 4]]}, "abstract": "<jats:p> Exaggerated proinflammatory cytokine responses can be observed with aging, and reduced levels of the anti-inflammatory cytokine IL-10 may contribute to these responses. IL-10 can reduce IL-6, IL-1\u03b2, and TNF-\u03b1 expression in nonmuscle tissues; however, no studies have examined the combined effects of IL-10 and age on cytokine responses in skeletal and cardiac muscle. These experiments tested the hypothesis that the absence of IL-10, in vivo, is associated with greater IL-6, TNF-\u03b1, and IL-1\u03b2 responses to an inflammatory challenge in skeletal and cardiac muscle and that aging exaggerates these responses. We compared IL-6, IL-1\u03b2, and TNF-\u03b1 mRNA and protein levels in skeletal and cardiac muscle of young (4 mo) and mature (10\u201311 mo) wild-type (IL-10<jats:sup>+/+</jats:sup>) and IL-10 deficient (IL-10<jats:sup>\u2212/\u2212</jats:sup>) mice following LPS. Skeletal and cardiac IL-6 mRNA and protein were elevated by LPS for IL-10<jats:sup>+/+</jats:sup> and IL-10<jats:sup>\u2212/\u2212</jats:sup> mice with greater responses in the IL-10<jats:sup>\u2212/\u2212</jats:sup> mice ( P &lt; 0.01). In skeletal muscle these effects were greater in mature than young mice ( P &lt; 0.01). IL-1\u03b2 mRNA and protein responses to LPS were greater in cardiac muscle of young but not mature IL-10<jats:sup>\u2212/\u2212</jats:sup> mice compared with IL-10<jats:sup>+/+</jats:sup> ( P &lt; 0.01). However, IL-1\u03b2 responses were greater in mature than young mice, but only in IL-10<jats:sup>+/+</jats:sup> groups ( P &lt; 0.05). The absence of IL-10 was associated with higher TNF-\u03b1 protein levels in cardiac muscle ( P &lt; 0.05). The results provide the first in vivo evidence that the absence of IL-10 is associated with a greater IL-6 response to LPS in skeletal and cardiac muscles, and in skeletal muscle aging further exaggerates these responses. </jats:p>", "DOI": "10.1152/japplphysiol.01079.2007", "type": "journal-article", "created": {"date-parts": [[2008, 1, 25]], "date-time": "2008-01-25T02:11:02Z", "timestamp": 1201227062000}, "page": "991-997", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Effects of IL-10 and age on IL-6, IL-1\u03b2, and TNF-\u03b1 responses in mouse skeletal and cardiac muscle to an acute inflammatory insult"], "prefix": "10.1152", "volume": "104", "author": [{"given": "B. M.", "family": "Meador", "sequence": "first", "affiliation": []}, {"given": "C. P.", "family": "Krzyszton", "sequence": "additional", "affiliation": []}, {"given": "R. W.", "family": "Johnson", "sequence": "additional", "affiliation": []}, {"given": "K. A.", "family": "Huey", "sequence": "additional", "affiliation": []}], "member": "24", "reference": [{"key": "R1", "DOI": "10.1016/S0006-8993(00)02392-1", "doi-asserted-by": "publisher"}, {"key": "R2", "DOI": "10.1016/S0065-2776(08)60532-5", "doi-asserted-by": "publisher"}, {"key": "R3", "DOI": "10.1152/ajpendo.00319.2002", "doi-asserted-by": "publisher"}, {"key": "R4", "DOI": "10.1086/320712", "doi-asserted-by": "publisher"}, {"key": "R5", "DOI": "10.1097/01.shk.0000196498.57306.a6", "doi-asserted-by": "publisher"}, {"key": "R6", "unstructured": "Chorinchath BB, Kong LY, Mao L, McCallum RE. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol 156: 1525\u20131530, 1996."}, {"key": "R7", "DOI": "10.1186/cc1822", "doi-asserted-by": "publisher"}, {"key": "R8", "DOI": "10.1006/cyto.1996.0169", "doi-asserted-by": "publisher"}, {"key": "R9", "DOI": "10.1016/j.cellimm.2005.10.003", "doi-asserted-by": "publisher"}, {"key": "R10", "DOI": "10.1096/fj.01-0876rev", "doi-asserted-by": "publisher"}, {"key": "R11", "DOI": "10.1016/0002-9149(93)90654-U", "doi-asserted-by": "publisher"}, {"key": "R12", "DOI": "10.1126/science.1631560", "doi-asserted-by": "publisher"}, {"key": "R13", "DOI": "10.1152/ajpregu.1992.262.2.R211", "doi-asserted-by": "publisher"}, {"key": "R14", "DOI": "10.1172/JCI6709", "doi-asserted-by": "publisher"}, {"key": "R15", "DOI": "10.1097/01.mco.0000165003.16578.2d", "doi-asserted-by": "publisher"}, {"key": "R16", "DOI": "10.1152/ajpregu.00164.2003", "doi-asserted-by": "publisher"}, {"key": "R17", "DOI": "10.1152/ajpregu.00039.2002", "doi-asserted-by": "publisher"}, {"key": "R18", "DOI": "10.1152/ajpregu.00490.2005", "doi-asserted-by": "publisher"}, {"key": "R19", "DOI": "10.3181/00379727-205-43695", "doi-asserted-by": "publisher"}, {"key": "R20", "DOI": "10.1097/01.mco.0000134364.61406.26", "doi-asserted-by": "publisher"}, {"key": "R21", "unstructured": "Hacham M, White RM, Argov S, Segal S, Apte RN. Interleukin-6 and interleukin-10 are expressed in organs of normal young and old mice. Eur Cytokine Netw 15: 37\u201346, 2004."}, {"key": "R22", "DOI": "10.1152/japplphysiol.01026.2004", "doi-asserted-by": "publisher"}, {"key": "R23", "DOI": "10.1096/fj.01-0507fje", "doi-asserted-by": "publisher"}, {"key": "R24", "DOI": "10.1016/j.bbrc.2003.09.048", "doi-asserted-by": "publisher"}, {"key": "R25", "DOI": "10.1093/emboj/20.14.3760", "doi-asserted-by": "publisher"}, {"key": "R26", "DOI": "10.1152/ajpendo.00507.2007", "doi-asserted-by": "publisher"}, {"key": "R27", "DOI": "10.1084/jem.183.3.949", "doi-asserted-by": "publisher"}, {"key": "R28", "DOI": "10.1097/01.shk.0000055237.25446.80", "doi-asserted-by": "publisher"}, {"key": "R29", "DOI": "10.1084/jem.179.5.1529", "doi-asserted-by": "publisher"}, {"key": "R30", "DOI": "10.1146/annurev.immunol.19.1.683", "doi-asserted-by": "publisher"}, {"key": "R31", "DOI": "10.1152/japplphysiol.00080.2007", "doi-asserted-by": "publisher"}, {"key": "R32", "DOI": "10.1016/j.tips.2007.02.002", "doi-asserted-by": "publisher"}, {"key": "R33", "DOI": "10.1111/j.1469-7793.2001.0329c.xd", "doi-asserted-by": "publisher"}, {"key": "R34", "DOI": "10.1152/japplphysiol.00164.2004", "doi-asserted-by": "publisher"}, {"key": "R35", "DOI": "10.1097/01.bor.0000245722.10136.6d", "doi-asserted-by": "publisher"}, {"key": "R36", "DOI": "10.1097/01.mco.0000068965.34812.62", "doi-asserted-by": "publisher"}, {"key": "R37", "DOI": "10.1074/jbc.M103740200", "doi-asserted-by": "publisher"}, {"key": "R38", "DOI": "10.1152/ajpheart.2000.279.5.H2241", "doi-asserted-by": "publisher"}, {"key": "R39", "DOI": "10.1016/j.mad.2003.08.002", "doi-asserted-by": "publisher"}, {"key": "R40", "DOI": "10.1016/j.amjmed.2005.10.049", "doi-asserted-by": "publisher"}, {"key": "R41", "DOI": "10.1006/abio.2000.4753", "doi-asserted-by": "publisher"}, {"key": "R42", "DOI": "10.1096/fj.02-0670fje", "doi-asserted-by": "publisher"}, {"key": "R43", "DOI": "10.1152/ajpcell.00509.2002", "doi-asserted-by": "publisher"}, {"key": "R44", "DOI": "10.1111/j.1469-7793.2000.00237.x", "doi-asserted-by": "publisher"}, {"key": "R45", "unstructured": "Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect Immun 64: 769\u2013774, 1996."}, {"key": "R46", "DOI": "10.1016/S0167-5699(97)01103-1", "doi-asserted-by": "publisher"}, {"key": "R47", "DOI": "10.1006/bbrc.1995.1168", "doi-asserted-by": "publisher"}, {"key": "R48", "DOI": "10.1172/JCI118398", "doi-asserted-by": "publisher"}, {"key": "R49", "DOI": "10.1093/gerona/57.5.M326", "doi-asserted-by": "publisher"}, {"key": "R50", "DOI": "10.1016/S0022-4804(03)00152-5", "doi-asserted-by": "publisher"}, {"key": "R51", "DOI": "10.1152/ajpcell.00142.2007", "doi-asserted-by": "publisher"}, {"key": "R52", "DOI": "10.1172/JCI1368", "doi-asserted-by": "publisher"}, {"key": "R53", "DOI": "10.1159/000049025", "doi-asserted-by": "publisher"}, {"key": "R54", "DOI": "10.1136/thx.2004.034181", "doi-asserted-by": "publisher"}, {"key": "R55", "DOI": "10.1016/j.bbadis.2005.12.012", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Applied Physiology"], "language": "en", "link": [{"URL": "https://www.physiology.org/doi/pdf/10.1152/japplphysiol.01079.2007", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 8]], "date-time": "2019-09-08T22:10:44Z", "timestamp": 1567980644000}, "score": 24.5741, "issued": {"date-parts": [[2008, 4]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2008, 4]]}, "issue": "4"}, "alternative-id": ["10.1152/japplphysiol.01079.2007"], "URL": "http://dx.doi.org/10.1152/japplphysiol.01079.2007", "relation": {"cites": []}, "ISSN": ["8750-7587", "1522-1601"], "issn-type": [{"value": "8750-7587", "type": "print"}, {"value": "1522-1601", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T02:58:56Z", "timestamp": 1574305136425}, "reference-count": 0, "publisher": "Microbiology Society", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Microbiology"], "published-print": {"date-parts": [[1997, 1, 1]]}, "DOI": "10.1099/00221287-143-1-45", "type": "journal-article", "created": {"date-parts": [[2009, 6, 5]], "date-time": "2009-06-05T04:53:32Z", "timestamp": 1244177612000}, "page": "45-53", "source": "Crossref", "is-referenced-by-count": 25, "title": ["TNF-\u00a0, IL-1\u00a0, IL-6 and ICAM-1 Expression in Human Keratinocytes Stimulated in Vitro with Escherichia Coli Heat-Shock Proteins"], "prefix": "10.1099", "volume": "143", "author": [{"given": "A.", "family": "Marcatili", "sequence": "first", "affiliation": []}, {"given": "G. C.", "family": "de I'Ero", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Galdiero", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Folgore", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Petrillo", "sequence": "additional", "affiliation": []}], "member": "345", "container-title": ["Microbiology"], "language": "en", "deposited": {"date-parts": [[2019, 8, 12]], "date-time": "2019-08-12T15:53:01Z", "timestamp": 1565625181000}, "score": 24.503347, "issued": {"date-parts": [[1997, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1099/00221287-143-1-45", "ISSN": ["1350-0872", "1465-2080"], "issn-type": [{"value": "1350-0872", "type": "print"}, {"value": "1465-2080", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T01:45:41Z", "timestamp": 1574127941520}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 1, 1]], "date-time": "1992-01-01T00:00:00Z", "timestamp": 694224000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cytokine"], "published-print": {"date-parts": [[1992, 1]]}, "DOI": "10.1016/1043-4666(92)90039-t", "type": "journal-article", "created": {"date-parts": [[2004, 5, 26]], "date-time": "2004-05-26T22:25:14Z", "timestamp": 1085610314000}, "page": "66-75", "source": "Crossref", "is-referenced-by-count": 75, "title": ["Differential effects of hemorrhage on kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release"], "prefix": "10.1016", "volume": "4", "author": [{"given": "A", "family": "AYALA", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Cytokine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:1043-4666(92)90039-T?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:1043-4666(92)90039-T?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 7]], "date-time": "2019-02-07T23:22:48Z", "timestamp": 1549581768000}, "score": 24.40741, "issued": {"date-parts": [[1992, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 1]]}, "issue": "1"}, "alternative-id": ["1043-4666(92)90039-T"], "URL": "http://dx.doi.org/10.1016/1043-4666(92)90039-t", "ISSN": ["1043-4666"], "issn-type": [{"value": "1043-4666", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:59:03Z", "timestamp": 1574470743783}, "reference-count": 40, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1779, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1111/j.1600-0625.2010.01174.x", "type": "journal-article", "created": {"date-parts": [[2010, 10, 18]], "date-time": "2010-10-18T12:37:25Z", "timestamp": 1287405445000}, "page": "48-52", "source": "Crossref", "is-referenced-by-count": 17, "title": ["TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP-1, and downstream gene transcription"], "prefix": "10.1111", "volume": "20", "author": [{"given": "Anna", "family": "Cla\u00dfen", "sequence": "first", "affiliation": []}, {"given": "Behnam N.", "family": "Kalali", "sequence": "additional", "affiliation": []}, {"given": "Christina", "family": "Schnopp", "sequence": "additional", "affiliation": []}, {"given": "Christian", "family": "Andres", "sequence": "additional", "affiliation": []}, {"given": "Juan A.", "family": "Aguilar-Pimentel", "sequence": "additional", "affiliation": []}, {"given": "Johannes", "family": "Ring", "sequence": "additional", "affiliation": []}, {"given": "Markus", "family": "Ollert", "sequence": "additional", "affiliation": []}, {"given": "Martin", "family": "Mempel", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 10, 18]]}, "reference": [{"key": "10.1111/j.1600-0625.2010.01174.x-BIB1|cit1", "author": "Leyden", "volume": "90", "first-page": "525", "year": "1974", "journal-title": "Br J Dermatol", "DOI": "10.1111/j.1365-2133.1974.tb06447.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB2|cit2", "author": "Aly", "volume": "113", "first-page": "780", "year": "1977", "journal-title": "Arch Dermatol", "DOI": "10.1001/archderm.113.6.780", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB3|cit3", "author": "Mempel", "volume": "22", "first-page": "306", "year": "2003", "journal-title": "Eur J Clin Microbiol Infect Dis"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB4|cit4", "author": "Breuer", "volume": "147", "first-page": "55", "year": "2002", "journal-title": "Br J Dermatol", "DOI": "10.1046/j.1365-2133.2002.04872.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB5|cit5", "author": "Hoeger", "volume": "165", "first-page": "1064", "year": "1992", "journal-title": "J Infect Dis", "DOI": "10.1093/infdis/165.6.1064", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB6|cit6", "author": "Cho", "volume": "108", "first-page": "269", "year": "2001", "journal-title": "J Allergy Clin Immunol", "DOI": "10.1067/mai.2001.117455", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB7|cit7", "author": "Kisich", "volume": "122", "first-page": "62", "year": "2008", "journal-title": "J Allergy Clin Immunol", "DOI": "10.1016/j.jaci.2008.04.022", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB8|cit8", "author": "Mrabet-Dahbi", "volume": "121", "first-page": "1013", "year": "2008", "journal-title": "J Allergy Clin Immunol", "DOI": "10.1016/j.jaci.2007.11.029", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB9|cit9", "author": "Niebuhr", "volume": "19", "first-page": "e296", "year": "2010", "journal-title": "Exp Dermatol", "DOI": "10.1111/j.1600-0625.2009.00989.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB10|cit10", "author": "Bunikowski", "volume": "105", "first-page": "814", "year": "2000", "journal-title": "J Allergy Clin Immunol", "DOI": "10.1067/mai.2000.105528", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB11|cit11", "author": "Bieber", "volume": "358", "first-page": "1483", "year": "2008", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMra074081", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB12|cit12", "author": "Miyata", "volume": "17", "first-page": "843", "year": "2008", "journal-title": "Exp Dermatol", "DOI": "10.1111/j.1600-0625.2008.00714.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB13|cit13", "author": "Orfali", "volume": "18", "first-page": "628", "year": "2009", "journal-title": "Exp Dermatol", "DOI": "10.1111/j.1600-0625.2009.00842.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB14|cit14", "author": "White", "volume": "113", "first-page": "179", "year": "1985", "journal-title": "Br J Dermatol", "DOI": "10.1111/j.1365-2133.1985.tb02062.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB15|cit15", "author": "Ezepchuk", "volume": "107", "first-page": "603", "year": "1996", "journal-title": "J Invest Dermatol", "DOI": "10.1111/1523-1747.ep12583377", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB16|cit16", "author": "Aufiero", "volume": "36", "first-page": "173", "year": "2004", "journal-title": "J Dermatol Sci", "DOI": "10.1016/j.jdermsci.2004.08.009", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB17|cit17", "author": "Kumar", "volume": "354", "first-page": "955", "year": "2007", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1016/j.bbrc.2007.01.072", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB18|cit18", "author": "Gomez", "volume": "10", "first-page": "842", "year": "2004", "journal-title": "Nat Med", "DOI": "10.1038/nm1079", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB19|cit19", "author": "Kalali", "volume": "181", "first-page": "2694", "year": "2008", "journal-title": "J Immunol", "DOI": "10.4049/jimmunol.181.4.2694", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB20|cit20", "author": "Mempel", "volume": "121", "first-page": "1389", "year": "2003", "journal-title": "J Invest Dermatol", "DOI": "10.1111/j.1523-1747.2003.12630.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB21|cit21", "author": "Kollisch", "volume": "114", "first-page": "531", "year": "2005", "journal-title": "Immunology", "DOI": "10.1111/j.1365-2567.2005.02122.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB22|cit22", "author": "Van Belkum", "volume": "46", "first-page": "222", "year": "1997", "journal-title": "J Med Microbiol", "DOI": "10.1099/00222615-46-3-222", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB23|cit23", "author": "Roben", "volume": "154", "first-page": "6437", "year": "1995", "journal-title": "J Immunol"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB24|cit24", "author": "Gomez", "volume": "281", "first-page": "20190", "year": "2006", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M601956200", "doi-asserted-by": "crossref"}, {"issue": "Suppl. 53", "key": "10.1111/j.1600-0625.2010.01174.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1046/j.1365-2133.1998.1390s3009.x", "volume": "139", "author": "Noble", "year": "1998", "journal-title": "Br J Dermatol"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB26|cit26", "author": "DeDent", "volume": "189", "first-page": "4473", "year": "2007", "journal-title": "J Bacteriol", "DOI": "10.1128/JB.00227-07", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB27|cit27", "author": "Gauger", "volume": "207", "first-page": "15", "year": "2003", "journal-title": "Dermatology", "DOI": "10.1159/000070935", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB28|cit28", "author": "Hartleib", "volume": "96", "first-page": "2149", "year": "2000", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB29|cit29", "author": "Leong", "volume": "15", "first-page": "1303", "year": "2000", "journal-title": "Histol Histopathol"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB30|cit30", "author": "Hamid", "volume": "94", "first-page": "870", "year": "1994", "journal-title": "J Clin Invest", "DOI": "10.1172/JCI117408", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB31|cit31", "author": "Liu", "volume": "203", "first-page": "269", "year": "2006", "journal-title": "J Exp Med", "DOI": "10.1084/jem.20051745", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB32|cit32", "author": "Leung", "volume": "105", "first-page": "37S", "year": "1995", "journal-title": "J Invest Dermatol", "DOI": "10.1111/1523-1747.ep12315250", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB33|cit33", "author": "Mempel", "volume": "111", "first-page": "452", "year": "1998", "journal-title": "J Invest Dermatol", "DOI": "10.1046/j.1523-1747.1998.00293.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB34|cit34", "author": "Boguniewicz", "volume": "108", "first-page": "651", "year": "2001", "journal-title": "J Allergy Clin Immunol", "DOI": "10.1067/mai.2001.118598", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB35|cit35", "author": "Lebre", "volume": "127", "first-page": "331", "year": "2007", "journal-title": "J Invest Dermatol", "DOI": "10.1038/sj.jid.5700530", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB36|cit36", "author": "Begon", "volume": "17", "first-page": "497", "year": "2007", "journal-title": "Eur J Dermatol"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB37|cit37", "author": "Travers", "volume": "120", "first-page": "789", "year": "2003", "journal-title": "J Invest Dermatol", "DOI": "10.1046/j.1523-1747.2003.12149.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB38|cit38", "author": "Wichmann", "volume": "161", "first-page": "300", "year": "2009", "journal-title": "Br J Dermatol", "DOI": "10.1111/j.1365-2133.2009.09229.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB39|cit39", "author": "Travers", "volume": "6", "first-page": "225", "year": "2001", "journal-title": "J Investig Dermatol Symp Proc", "DOI": "10.1046/j.0022-202x.2001.00045.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0625.2010.01174.x-BIB40|cit40", "author": "Travers", "volume": "125", "first-page": "146", "year": "2010", "journal-title": "J Allergy Clin Immunol", "DOI": "10.1016/j.jaci.2009.09.052", "doi-asserted-by": "crossref"}], "container-title": ["Experimental Dermatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0625.2010.01174.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T15:12:14Z", "timestamp": 1497885134000}, "score": 24.2236, "subtitle": ["TNF receptor I on human keratinocytes"], "issued": {"date-parts": [[2010, 10, 18]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1111/j.1600-0625.2010.01174.x", "relation": {"cites": []}, "ISSN": ["0906-6705"], "issn-type": [{"value": "0906-6705", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:41:23Z", "timestamp": 1574498483642}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "issue": "08", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Z Gastroenterol"], "DOI": "10.1055/s-0032-1324133", "type": "journal-article", "created": {"date-parts": [[2012, 8, 22]], "date-time": "2012-08-22T22:37:47Z", "timestamp": 1345675067000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterized by interferon-gamma-expressing Th1 and IL-17/IL-22-expressing Th17 cell infiltrates and respond to anti-IL-12/IL-23 antibody treatment"], "prefix": "10.1055", "volume": "50", "author": [{"given": "C", "family": "Tillack", "sequence": "first", "affiliation": []}, {"given": "L", "family": "Ehmann", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Koglin", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Schauber", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Wollenberg", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Brand", "sequence": "additional", "affiliation": []}], "member": "194", "published-online": {"date-parts": [[2012, 8, 22]]}, "container-title": ["Zeitschrift f\u00fcr Gastroenterologie"], "language": "de", "link": [{"URL": "http://www.thieme-connect.de/DOI/DOI?10.1055/s-0032-1324133", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 13]], "date-time": "2017-06-13T08:06:03Z", "timestamp": 1497341163000}, "score": 24.19025, "issued": {"date-parts": [[2012, 8, 22]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 8, 15]]}, "published-print": {"date-parts": [[2012, 8]]}, "issue": "08"}, "URL": "http://dx.doi.org/10.1055/s-0032-1324133", "ISSN": ["0044-2771", "1439-7803"], "issn-type": [{"value": "0044-2771", "type": "print"}, {"value": "1439-7803", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T22:13:56Z", "timestamp": 1575324836868}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 11, 1]], "date-time": "2008-11-01T00:00:00Z", "timestamp": 1225497600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Integrative Medicine"], "published-print": {"date-parts": [[2008, 11]]}, "DOI": "10.1016/j.eujim.2008.08.105", "type": "journal-article", "created": {"date-parts": [[2008, 11, 20]], "date-time": "2008-11-20T13:23:31Z", "timestamp": 1227187411000}, "page": "12", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Anti-inflammatory abilities of Imupret\u00ae: Inhibition of IL-8 and human \u03b2-defensin 2 induced by LPS and IL-1\u03b2 in lung epithelial A549 cells"], "prefix": "10.1016", "volume": "1", "author": [{"given": "K.", "family": "Hostanska", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Melzer", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Amon", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Saller", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Integrative Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1876382008001066?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1876382008001066?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 24]], "date-time": "2018-12-24T08:20:07Z", "timestamp": 1545639607000}, "score": 23.925245, "issued": {"date-parts": [[2008, 11]]}, "references-count": 0, "alternative-id": ["S1876382008001066"], "URL": "http://dx.doi.org/10.1016/j.eujim.2008.08.105", "ISSN": ["1876-3820"], "issn-type": [{"value": "1876-3820", "type": "print"}], "subject": ["Complementary and alternative medicine"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:20:12Z", "timestamp": 1574486412763}, "reference-count": 94, "publisher": "Informa UK Limited", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Review of Dermatology"], "published-print": {"date-parts": [[2012, 6]]}, "DOI": "10.1586/edm.12.18", "type": "journal-article", "created": {"date-parts": [[2012, 7, 5]], "date-time": "2012-07-05T18:53:21Z", "timestamp": 1341514401000}, "page": "283-293", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Effective topical agents and emerging perspectives in the treatment of psoriasis"], "prefix": "10.1586", "volume": "7", "author": [{"given": "Andrea", "family": "Chiricozzi", "sequence": "first", "affiliation": []}, {"given": "Sergio", "family": "Chimenti", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 1, 10]]}, "reference": [{"key": "CIT0001", "author": "Liu", "volume": "8", "first-page": "1", "year": "2007", "journal-title": "Genes Immun.", "DOI": "10.1038/sj.gene.6364351", "doi-asserted-by": "crossref"}, {"key": "CIT0002", "DOI": "10.1038/nri1689", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Voorhees", "volume": "28", "first-page": "467", "year": "1977", "journal-title": "Annu. Rev. Med.", "DOI": "10.1146/annurev.me.28.020177.002343", "doi-asserted-by": "crossref"}, {"key": "CIT0004", "author": "Barker", "volume": "2", "first-page": "106", "year": "1991", "journal-title": "J. Dermatol. Sci.", "DOI": "10.1016/0923-1811(91)90019-T", "doi-asserted-by": "crossref"}, {"key": "CIT0005", "DOI": "10.1038/sj.jid.5701213", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1038/nature04753", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1016/j.immuni.2008.03.004", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1038/nature07036", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1038/nature07021", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1084/jem.20060285", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1074/jbc.M207577200", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1016/S1074-7613(00)00070-4", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1136/ard.2004.031237", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1038/jid.2010.103", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "author": "Gisondi", "volume": "18", "first-page": "297", "year": "2010", "journal-title": "Acta Dermatovenerol. Croat."}, {"key": "CIT0016", "DOI": "10.1159/000090652", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1001/jama.272.22.1757", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1016/j.jaad.2008.12.032", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "author": "van de Kerkhof", "volume": "22", "first-page": "859", "year": "2008", "journal-title": "J. Eur. Acad. Dermatol. Venereol.", "DOI": "10.1111/j.1468-3083.2007.02534.x", "doi-asserted-by": "crossref"}, {"key": "CIT0020", "author": "Adcock", "volume": "55", "first-page": "256", "year": "2000", "journal-title": "Monaldi Arch. Chest Dis."}, {"key": "CIT0021", "DOI": "10.1016/S0165-5728(00)00297-6", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "author": "Mitra", "volume": "7", "first-page": "977", "year": "2010", "journal-title": "Expert Opin. Drug Deliv.", "DOI": "10.1517/17425247.2010.503953", "doi-asserted-by": "crossref"}, {"key": "CIT0024", "author": "Horn", "volume": "24", "first-page": "119", "year": "2010", "journal-title": "J. Eur. Acad. Dermatol. Venereol.", "DOI": "10.1111/j.1468-3083.2009.03358.x", "doi-asserted-by": "crossref"}, {"key": "CIT0025", "author": "Bernhard", "volume": "25", "first-page": "1170", "year": "1991", "journal-title": "J. Am. Acad. Dermatol.", "DOI": "10.1016/0190-9622(91)70320-2", "doi-asserted-by": "crossref"}, {"key": "CIT0026", "author": "Sears", "volume": "14", "first-page": "140", "year": "1997", "journal-title": "Adv. Ther."}, {"key": "CIT0027", "author": "Pauporte", "volume": "15", "first-page": "360", "year": "2004", "journal-title": "J. Dermatolog. Treat.", "DOI": "10.1080/09546630410023566", "doi-asserted-by": "crossref"}, {"key": "CIT0028", "author": "Lebwohl", "volume": "41", "first-page": "269", "year": "2002", "journal-title": "Int. J. Dermatol", "DOI": "10.1046/j.1365-4362.2002.01431.x", "doi-asserted-by": "crossref"}, {"key": "CIT0029", "author": "Hill", "volume": "21", "first-page": "624", "year": "1978", "journal-title": "Cutis"}, {"key": "CIT0030", "author": "du Vivier", "volume": "111", "first-page": "581", "year": "1975", "journal-title": "Arch. Dermatol.", "DOI": "10.1001/archderm.1975.01630170039002", "doi-asserted-by": "crossref"}, {"key": "CIT0031", "DOI": "10.1111/j.1365-2133.2006.07236.x", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "author": "Maibach", "volume": "31", "first-page": "21", "year": "1992", "journal-title": "Int. J. Dermatol.", "DOI": "10.1111/j.1365-4362.1992.tb04008.x", "doi-asserted-by": "crossref"}, {"key": "CIT0033", "DOI": "10.1016/S0190-9622(97)70320-7", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "author": "Reichrath", "volume": "77", "first-page": "268", "year": "1997", "journal-title": "Acta Derm. Venereol."}, {"key": "CIT0035", "DOI": "10.1016/j.jaci.2011.01.068", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1002/jcb.10335", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "author": "Kragballe", "volume": "125", "first-page": "1647", "year": "1989", "journal-title": "Arch. Dermatol.", "DOI": "10.1001/archderm.1989.01670240047011", "doi-asserted-by": "crossref"}, {"key": "CIT0038", "DOI": "10.1046/j.1365-2133.2002.04567.x", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "author": "Baadsgaard", "volume": "6", "first-page": "145", "year": "1995", "journal-title": "J. Dermatolog. Treat.", "DOI": "10.3109/09546639509097171", "doi-asserted-by": "crossref"}, {"key": "CIT0040", "author": "Carmelo", "volume": "6", "first-page": "142", "year": "1996", "journal-title": "J. Eur. Acad. Dermatol. Venereol.", "DOI": "10.1111/j.1468-3083.1996.tb00157.x", "doi-asserted-by": "crossref"}, {"key": "CIT0041", "author": "Camarasa", "volume": "14", "first-page": "8", "year": "2003", "journal-title": "J. Dermatolog. Treat.", "DOI": "10.1080/09546630305545", "doi-asserted-by": "crossref"}, {"key": "CIT0042", "DOI": "10.1046/j.1365-2133.1999.02975.x", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1016/j.jaad.2005.04.027", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "author": "Ruzicka", "volume": "138", "first-page": "254", "year": "1998", "journal-title": "Br. J. Dermatol.", "DOI": "10.1046/j.1365-2133.1998.02070.x", "doi-asserted-by": "crossref"}, {"key": "CIT0045", "author": "Saraceno", "volume": "10", "first-page": "2357", "year": "2009", "journal-title": "Expert Opin. Pharmacother.", "DOI": "10.1517/14656560903198960", "doi-asserted-by": "crossref"}, {"key": "CIT0046", "DOI": "10.1016/j.jaad.2002.12.002", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1159/000080854", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "author": "Calcaterra", "first-page": "26", "journal-title": "Castellaneta Marina, Italy"}, {"key": "CIT0049", "DOI": "10.1046/j.1365-2133.2002.04967.x", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1067/mjd.2003.130", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "DOI": "10.1080/00015550252948194", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "author": "Tr\u00e9mezaygues", "volume": "3", "first-page": "180", "year": "2011", "journal-title": "Dermatoendocrinol.", "DOI": "10.4161/derm.17534", "doi-asserted-by": "crossref"}, {"key": "CIT0053", "author": "Fleming", "volume": "20", "first-page": "465", "year": "2010", "journal-title": "Eur. J. Dermatol."}, {"key": "CIT0054", "DOI": "10.1159/000323408", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "DOI": "10.1016/S0190-9622(97)70216-0", "doi-asserted-by": "publisher"}, {"key": "CIT0056", "DOI": "10.1067/mjd.2003.103", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "author": "Veraldi", "volume": "212", "first-page": "235", "year": "2006", "journal-title": "Dermatology", "DOI": "10.1159/000091250", "doi-asserted-by": "crossref"}, {"key": "CIT0058", "author": "Koo", "volume": "43", "first-page": "821", "year": "2000", "journal-title": "J. Am. Acad. Dermatol.", "DOI": "10.1067/mjd.2000.107940", "doi-asserted-by": "crossref"}, {"key": "CIT0059", "author": "Stern", "volume": "1", "first-page": "732", "year": "1980", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(80)91231-3", "doi-asserted-by": "crossref"}, {"key": "CIT0060", "author": "Silverman", "volume": "13", "first-page": "817", "year": "1995", "journal-title": "Dermatol. Clin.", "DOI": "10.1016/S0733-8635(18)30045-7", "doi-asserted-by": "crossref"}, {"key": "CIT0061", "author": "Fiore", "volume": "46", "first-page": "351", "year": "1990", "journal-title": "Cutis"}, {"key": "CIT0062", "author": "Mrowietz", "volume": "136", "first-page": "542", "year": "1997", "journal-title": "Br. J. Dermatol.", "DOI": "10.1111/j.1365-2133.1997.tb02138.x", "doi-asserted-by": "crossref"}, {"key": "CIT0063", "author": "Lebwohl", "volume": "38", "first-page": "16", "year": "1999", "journal-title": "Int. J. Dermatol.", "DOI": "10.1046/j.1365-4362.1999.00500.x", "doi-asserted-by": "crossref"}, {"key": "CIT0064", "author": "Bruner", "volume": "9", "first-page": "2", "year": "2003", "journal-title": "Dermatol. Online J."}, {"key": "CIT0065", "DOI": "10.1001/archderm.134.9.1101", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "author": "Brune", "volume": "24", "first-page": "76", "year": "2007", "journal-title": "Pediatr. Dermatol.", "DOI": "10.1111/j.1525-1470.2007.00341.x", "doi-asserted-by": "crossref"}, {"key": "CIT0067", "DOI": "10.1016/j.jaad.2005.05.036", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "author": "Bissonnette", "volume": "12", "first-page": "230", "year": "2008", "journal-title": "J. Cutan. Med. Surg.", "DOI": "10.2310/7750.2008.07055", "doi-asserted-by": "crossref"}, {"key": "CIT0069", "DOI": "10.1067/mjd.2003.169", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "DOI": "10.1016/j.jaad.2004.07.011", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "author": "Yamamoto", "volume": "13", "first-page": "471", "year": "2003", "journal-title": "Eur. J. Dermatol."}, {"key": "CIT0072", "DOI": "10.1016/j.jaad.2004.06.010", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "unstructured": "Newbold PCH. Pruritus in psoriasis. In:Psoriasis: Proceedings of the Second International Symposium.Farber EM, Cox AJ (Eds). Yorke Medical Books, NY, USA, 334\u2013336 (1977)."}, {"key": "CIT0074", "author": "Saraceno", "volume": "155", "first-page": "876", "year": "2006", "journal-title": "Br. J. Dermatol.", "DOI": "10.1111/j.1365-2133.2006.07518.x", "doi-asserted-by": "crossref"}, {"key": "CIT0075", "author": "Payan", "volume": "132", "first-page": "1601", "year": "1984", "journal-title": "J. Immunol."}, {"key": "CIT0076", "author": "Pincelli", "volume": "10", "first-page": "85", "year": "2000", "journal-title": "Eur. J. Dermatol."}, {"key": "CIT0077", "author": "Girolomoni", "volume": "145", "first-page": "1105", "year": "1990", "journal-title": "J. Immunol."}, {"key": "CIT0078", "DOI": "10.1111/j.0022-202X.2003.12602.x", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.4049/jimmunol.178.5.2623", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "author": "Subramaniam", "volume": "262", "first-page": "14", "year": "1999", "journal-title": "Biochem. Biophys. Res. Commun.", "DOI": "10.1006/bbrc.1999.1156", "doi-asserted-by": "crossref"}, {"key": "CIT0081", "author": "Changelian", "volume": "302", "first-page": "875", "year": "2003", "journal-title": "Science", "DOI": "10.1126/science.1087061", "doi-asserted-by": "crossref"}, {"key": "CIT0082", "DOI": "10.1046/j.1600-6143.2003.00281.x", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "author": "Punwani", "journal-title": "J. Am. Acad. Dermatol."}, {"key": "CIT0084", "author": "Muramoto", "volume": "335", "first-page": "23", "year": "2010", "journal-title": "J. Pharmacol. Exp. Ther.", "DOI": "10.1124/jpet.110.168583", "doi-asserted-by": "crossref"}, {"key": "CIT0085", "author": "Goto", "volume": "331", "first-page": "485", "year": "2009", "journal-title": "J. Pharmacol. Exp. Ther.", "DOI": "10.1124/jpet.109.156554", "doi-asserted-by": "crossref"}, {"key": "CIT0086", "author": "Bissonnette", "journal-title": "J. Eur. Acad. Dermatol. Venereol."}, {"key": "CIT0087", "author": "Bissonnette", "volume": "146", "first-page": "446", "year": "2010", "journal-title": "Arch. Dermatol.", "DOI": "10.1001/archdermatol.2010.34", "doi-asserted-by": "crossref"}, {"key": "CIT0088", "author": "Nazarian", "volume": "10", "first-page": "1236", "year": "2009", "journal-title": "Curr. Opin. Investig. Drugs"}, {"key": "CIT0089", "DOI": "10.1016/j.bmcl.2009.03.007", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "author": "Sano", "volume": "65", "first-page": "5720", "year": "2005", "journal-title": "Cancer Res.", "DOI": "10.1158/0008-5472.CAN-04-4359", "doi-asserted-by": "crossref"}, {"key": "CIT0091", "author": "Tohyama", "volume": "39", "first-page": "2779", "year": "2009", "journal-title": "Eur. J. Immunol.", "DOI": "10.1002/eji.200939473", "doi-asserted-by": "crossref"}, {"key": "CIT0092", "author": "Sartor", "volume": "57", "first-page": "978", "year": "1997", "journal-title": "Cancer Res."}, {"key": "CIT0093", "DOI": "10.1038/jid.2010.255", "doi-asserted-by": "publisher"}, {"key": "CIT0094", "DOI": "10.1007/s00403-005-0626-0", "doi-asserted-by": "publisher"}, {"key": "CIT0095", "DOI": "10.1016/j.pupt.2005.07.004", "doi-asserted-by": "publisher"}], "container-title": ["Expert Review of Dermatology"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1586/edm.12.18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 30]], "date-time": "2019-06-30T15:33:01Z", "timestamp": 1561908781000}, "score": 23.899193, "issued": {"date-parts": [[2012, 6]]}, "references-count": 94, "journal-issue": {"published-online": {"date-parts": [[2014, 1, 10]]}, "published-print": {"date-parts": [[2012, 6]]}, "issue": "3"}, "alternative-id": ["10.1586/edm.12.18"], "URL": "http://dx.doi.org/10.1586/edm.12.18", "relation": {"cites": []}, "ISSN": ["1746-9872", "1746-9880"], "issn-type": [{"value": "1746-9872", "type": "print"}, {"value": "1746-9880", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T23:40:03Z", "timestamp": 1576626003042}, "reference-count": 41, "publisher": "Elsevier BV", "issue": "12", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 12, 1]], "date-time": "1999-12-01T00:00:00Z", "timestamp": 944006400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cytokine"], "published-print": {"date-parts": [[1999, 12]]}, "DOI": "10.1006/cyto.1999.0505", "type": "journal-article", "created": {"date-parts": [[2002, 10, 7]], "date-time": "2002-10-07T14:19:07Z", "timestamp": 1034000347000}, "page": "1020-1030", "source": "Crossref", "is-referenced-by-count": 28, "title": ["DIFFERENTIAL EFFECTS OF IL-8, LIF (PRO-INFLAMMATORY) AND IL-11 (ANTI-INFLAMMATORY) ON TNF-\u03b1-INDUCED PGE2RELEASE AND ON SIGNALLING PATHWAYS IN HUMAN OA SYNOVIAL FIBROBLASTS"], "prefix": "10.1006", "volume": "11", "author": [{"given": "Nada", "family": "Alaaeddine", "sequence": "first", "affiliation": []}, {"given": "John A", "family": "Di Battista", "sequence": "additional", "affiliation": []}, {"given": "Jean-Pierre", "family": "Pelletier", "sequence": "additional", "affiliation": []}, {"given": "Kayghobad", "family": "Kiansa", "sequence": "additional", "affiliation": []}, {"given": "Jean-Marie", "family": "Cloutier", "sequence": "additional", "affiliation": []}, {"given": "Johanne", "family": "Martel-Pelletier", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cytokine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1043466699905057?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1043466699905057?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T23:01:29Z", "timestamp": 1576623689000}, "score": 23.84477, "issued": {"date-parts": [[1999, 12]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[1999, 12]]}, "issue": "12"}, "alternative-id": ["S1043466699905057"], "URL": "http://dx.doi.org/10.1006/cyto.1999.0505", "ISSN": ["1043-4666"], "issn-type": [{"value": "1043-4666", "type": "print"}], "subject": ["Immunology", "Immunology and Allergy", "Biochemistry", "Molecular Biology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:16:18Z", "timestamp": 1574327778029}, "reference-count": 10, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Personal Selling & Sales Management"], "published-print": {"date-parts": [[2009, 9]]}, "DOI": "10.2753/pss0885-3134290401", "type": "journal-article", "created": {"date-parts": [[2009, 10, 9]], "date-time": "2009-10-09T01:05:47Z", "timestamp": 1255050347000}, "page": "305-320", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Key Account Management: Adding Elements of Account Fit to an Integrative Theoretical Framework"], "prefix": "10.1080", "volume": "29", "author": [{"given": "Keith A.", "family": "Richards", "sequence": "first", "affiliation": []}, {"given": "Eli", "family": "Jones", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2013, 9, 23]]}, "reference": [{"key": "CIT0010", "unstructured": "Chin, Wynne W. (1998), \u201cModern Methods for Business Research,\u201d in The Partial Least Squares Approach to Structural Equation Modeling, George A. Marcoulides, ed., Mahwah, NJ: Lawrence Erlbaum, 295\u2013336."}, {"key": "CIT0051", "unstructured": "Parvatiyar, Atul, and Jagdish N. Sheth (2000), \u201cThe Domain and Conceptual Foundations of Relationship Marketing,\u201d In Handbook of Relationship Marketing, Jagdish N. Sheth and Atul Parvatiyar, eds., Thousand Oaks, CA: Sage, 3\u201338.", "DOI": "10.4135/9781452231310.n1", "doi-asserted-by": "crossref"}, {"key": "CIT0052", "unstructured": "Pegram, Roger M. (1972), Selling and Servicing the National Account, New York: Conference Board."}, {"key": "CIT0053", "unstructured": "Platzer, Linda Cardillo (1984), Managing National Accounts, New York: Conference Board."}, {"key": "CIT0056", "unstructured": "Rackham, Neil, and John DeVincentis (1999), Rethinking the Sales Force: Redefining Selling to Create and Capture Customer Value, New York: McGraw-Hill."}, {"key": "CIT0068", "unstructured": "Shapiro, Benson P., and Rowland T. Moriarty (1980), \u201cNational Account Management,\u201d Working Paper no. 80\u2013104, Marketing Science Institute, Cambridge, MA."}, {"key": "CIT0069", "unstructured": "Shapiro, Benson P., and Rowland T. Moriarty (1982), \u201cNational Account Management: Emerging Insights,\u201d Working Paper no. 82\u2013100, Marketing Science Institute, Cambridge, MA."}, {"key": "CIT0070", "unstructured": "Shapiro, Benson P., and Rowland T. Moriarty (1984a), \u201cOrganizing the National Account Force,\u201d Working Paper no. 84\u2013101, Marketing Science Institute, Cambridge, MA."}, {"key": "CIT0071", "unstructured": "Shapiro, Benson P., and Rowland T. Moriarty (1984b), \u201cSupport Systems for National Account Management Programs,\u201d Working Paper no. 84\u2013102, Marketing Science Institute, Cambridge, MA."}, {"key": "CIT0085", "unstructured": "Zaltman, Gerald, Karen LeMasters, and Michael Heffring (1982), Theory Construction in Marketing: Some Thoughts on Thinking, New York: John Wiley."}], "container-title": ["Journal of Personal Selling & Sales Management"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.2753/PSS0885-3134290401", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 18]], "date-time": "2017-09-18T14:37:15Z", "timestamp": 1505745435000}, "score": 23.800003, "issued": {"date-parts": [[2009, 9]]}, "references-count": 10, "journal-issue": {"published-online": {"date-parts": [[2013, 9, 23]]}, "published-print": {"date-parts": [[2009, 9]]}, "issue": "4"}, "alternative-id": ["10.2753/PSS0885-3134290401"], "URL": "http://dx.doi.org/10.2753/pss0885-3134290401", "relation": {"cites": []}, "ISSN": ["0885-3134", "1557-7813"], "issn-type": [{"value": "0885-3134", "type": "print"}, {"value": "1557-7813", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}